<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-6037355450143152524</id><updated>2012-02-15T23:14:51.051-08:00</updated><category term='DDI'/><category term='allergies'/><category term='Uncategorized'/><category term='web2.0'/><category term='RxNorm'/><category term='pharmacy'/><category term='web'/><category term='2.0'/><category term='CPOE'/><category term='cds'/><category term='bcma'/><title type='text'>Pharmacy Informatics Exchange</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>64</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2419777893687013323</id><published>2009-03-31T06:39:00.000-07:00</published><updated>2009-03-31T06:59:04.333-07:00</updated><title type='text'>RxInformatics.com instead</title><content type='html'>Please go to the following site for ongoing blog post and discussions.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://rxinformatics.com/"&gt;http://rxinformatics.com/&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://rxinformatics.com/"&gt;RxInformatics&lt;/a&gt; is a collaborative site with Chad Hardy and John Poikonen.  Rather than support his blog, I will be consolidating on &lt;a href="http://rxinformatics.com/"&gt;this site&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;I will cross post to my personal blog as well at &lt;a href="http://rxdoc.org/"&gt;http://rxdoc.org/&lt;/a&gt; or &lt;a href="http://pharmacyinformatics.wordpress.com/"&gt;http://pharmacyinformatics.wordpress.com/&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Thank you all for your comments and interest!&lt;br /&gt;&lt;br /&gt;John Poikonen, PharmD&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2419777893687013323?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2419777893687013323/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/rxinformaticscom-instead.html#comment-form' title='3 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2419777893687013323'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2419777893687013323'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/rxinformaticscom-instead.html' title='RxInformatics.com instead'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-1747226130098961217</id><published>2009-03-30T10:16:00.001-07:00</published><updated>2009-03-31T06:39:45.479-07:00</updated><title type='text'>ASHP Hypocrisy</title><content type='html'>&lt;p&gt;I have commented on the cluelessness of Am Soc of Health System Pharmacists (ASHP) on-line publishing model in the past via &lt;a href="http://www.ashp.org/ashpconnect/forum/messageview.aspx?catid=30&amp;amp;threadid=54&amp;amp;enterthread=y"&gt;their forums&lt;/a&gt;.&lt;/p&gt;    &lt;p&gt; My motivation for this is to get them to wake up and realize the potential of a full scale on line presence and to get them off of their antiquated paper publishing model before they go by the way of the &lt;a href="http://www.denverpost.com/breakingnews/ci_11791798"&gt;Rocky Mountain News&lt;/a&gt; and &lt;a href="http://beltwayblips.dailyradar.com/story/seattle_times_still_standing_but_for_how_long/"&gt;Seattle Intelligencer&lt;/a&gt;&lt;/p&gt;    &lt;p&gt; A new bizarre irony and hypocritical situation has emerged. While endorsing electronic medical records they still will not allow members to opt out of getting publications on paper. &lt;span&gt; &lt;/span&gt;Their &lt;a href="http://www.ajhp.org/"&gt;journal&lt;/a&gt; is extremely valuable and of high quality that I read religiously on lne. &lt;span&gt; &lt;/span&gt;Every two weeks a large (rather nice, but incredibly wasteful) package arrives.&lt;span&gt;  &lt;/span&gt;Every two weeks I populate my town’s landfill with more waste.&lt;/p&gt;  &lt;p&gt;&lt;/p&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com/"&gt;Posted via web&lt;/a&gt;   from &lt;a href="http://rxdoc.org/ashp-hypocrisy"&gt;RxDoc.Org&lt;/a&gt;  &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-1747226130098961217?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/1747226130098961217/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/ashp-hypocrisy.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1747226130098961217'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1747226130098961217'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/ashp-hypocrisy.html' title='ASHP Hypocrisy'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-868090999534909375</id><published>2009-03-21T18:06:00.001-07:00</published><updated>2009-03-21T18:06:22.270-07:00</updated><title type='text'>
Why is there not a Sermo for Pharmacists?  Lets start one  </title><content type='html'>&lt;br /&gt;&lt;p&gt;See &lt;a href="http://www.sermo.com/"&gt;http://www.sermo.com/&lt;/a&gt;&lt;/p&gt;  &lt;p&gt;&lt;span&gt;The Sermo business model is based on &amp;ldquo;Information Arbitrage.&amp;rdquo;&lt;/span&gt; This is the opportunity that arises when breaking medical insights intersect with the demand for actionable, market-changing events in healthcare. Our clients include some of the nation&amp;rsquo;s most prestigious healthcare companies, financial services institutions and government agencies: any organization that can benefit from early insight into clinical events. These parties create a financial incentive that is used to generate, sustain, and support participation in the online physician community.&lt;/p&gt;  &lt;div&gt;&lt;img src="http://www.sermo.com/images/how_money_screenshot.gif" alt="" /&gt;&lt;/div&gt;  &lt;h3&gt;Through information arbitrage, our clients are able to:&lt;/h3&gt;  &lt;ul&gt;  &lt;li&gt; Help forecast potential problems or new uses for commercially significant medical products and therapies&lt;/li&gt;  &lt;li&gt; Gain early insight into outbreaks and other changes in disease states and conditions that can affect the public health&lt;/li&gt;  &lt;li&gt; Perform epidemiologic research investigations&lt;/li&gt;  &lt;li&gt; Perform real-time surveys of the opinion of practicing physicians on topics related to medical care&lt;/li&gt;  &lt;li&gt; Assess the success and adoption of best practice recommendations&lt;/li&gt;  &lt;li&gt; Find opportunities to improve medical practice, and protect and promote patient safety and the public health&lt;/li&gt;  &lt;/ul&gt;  &lt;p&gt;Clients pay a subscription fee and in return can post questions to the Sermo community. If you vote on one of these postings, you may be financially rewarded for your astute observations.&lt;/p&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via web&lt;/a&gt;   from &lt;a href="http://rxdoc.org/why-is-there-not-a-sermo-for-pharmacists-lets"&gt;RxDoc.Org&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-868090999534909375?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/868090999534909375/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/why-is-there-not-sermo-for-pharmacists.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/868090999534909375'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/868090999534909375'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/why-is-there-not-sermo-for-pharmacists.html' title='&#xA;Why is there not a Sermo for Pharmacists?  Lets start one  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4198186251023275132</id><published>2009-03-21T15:05:00.001-07:00</published><updated>2009-03-21T15:05:04.746-07:00</updated><title type='text'>
(NQF) has revised its list of practices that have proven effective in 	reducing adverse events - Pharmacy Informatics perspective  </title><content type='html'>&lt;br /&gt;The National Quality Forum (NQF) has revised its &lt;a href="http://www.qualityforum.org/publications/reports/safe_practices_2009.asp"&gt;list of practices&lt;/a&gt; that have &lt;b&gt;proven effective in reducing adverse events&lt;/b&gt;.  This is a very impressive list of practices.  It also revealing what is not on the list.&lt;br /&gt;  &lt;br /&gt;From  a pure pharmacy informatics perspective the following practices are  good to see.  CPOE and Pharmacy leadership are, of course, welcome  additions to this list.  Using technology to enhance medication  reconciliation and antimicrobial stewardship will go a long way to  enhancing care as well and need a full court press by pharmacy and  informatic departments.&lt;br /&gt;  &lt;br /&gt;Bar Code Medication Administration  (BCMA) is not on the list.  This is not a big surprise.  I have settled  into a role and view of a counter balance to most of my pharmacy  colleagues.  There is a wide effort to implement BCMA to decrease  adverse events without much evidence that it does anything.   Spouting  a negative view on this practice is not comfortable nor one that I  believe will last forever.  I fully believe that this practice will  eventually be proven effective.  At this time it clearly is not.  Given  this list of these proven practices, spending time and effort on BCMA  if all of these practices are not fully exploted, may even be harmful.   We all have limited resources and time taken away from proven practices  to ones of dubious value needs to be evaluated.&lt;br /&gt;  &lt;br /&gt;What say you?&lt;br /&gt;&lt;br /&gt;John Poikonen&lt;br /&gt;&lt;a href="mailto:john@poikonen.NET"&gt;john@poikonen.NET&lt;/a&gt;&lt;br /&gt;&lt;a href="http://twitter.com/poikonen"&gt;http://twitter.com/poikonen&lt;/a&gt;&lt;br /&gt;  Blog = &lt;a href="http://pharmacyinformatics.wordpress.com/"&gt;http://pharmacyinformatics.wordpress.com/&lt;/a&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via email&lt;/a&gt;   from &lt;a href="http://rxdoc.org/nqf-has-revised-its-list-of-pr-0"&gt;RxDoc.Org&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4198186251023275132?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4198186251023275132/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/nqf-has-revised-its-list-of-practices_21.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4198186251023275132'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4198186251023275132'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/nqf-has-revised-its-list-of-practices_21.html' title='&#xA;(NQF) has revised its list of practices that have proven effective in &#x9;reducing adverse events - Pharmacy Informatics perspective  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-861860110513173731</id><published>2009-03-19T10:25:00.001-07:00</published><updated>2009-03-19T10:44:03.553-07:00</updated><title type='text'>No More NUPOR Mooing and Musings #3</title><content type='html'>&lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;The first article on NUPOR is out in the April 1&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;sup&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;st&lt;/span&gt;&lt;/sup&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;, Am J Health System Pharmacy.  It is&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt; brilliant and will change the face of pharmacy&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt; as we know it (IMHO of course).&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;Opportunity cost of pharmacists’ nearly universal prospective order review &lt;/span&gt;&lt;/p&gt;  &lt;ul dir="ltr"&gt;&lt;ul dir="ltr"&gt;  &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;Allen J. Flynn&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;Am J Health Syst Pharm 2009;66 668-670&lt;br /&gt; &lt;/span&gt;&lt;a href="http://www.ajhp.org/cgi/content/full/66/7/668?etoc"&gt;&lt;span lang="en-us"&gt;&lt;u&gt;&lt;span style="color:#0000ff;"&gt;http://www.ajhp.org/cgi/content/full/66/7/668&lt;/span&gt;&lt;/u&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/a&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/p&gt;  &lt;/ul&gt;&lt;/ul&gt;  &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;I will have a letter in response (and support) of this from an informatics point of view in the&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;next issue,&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;April 15&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;sup&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;th&lt;/span&gt;&lt;/sup&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt; AJHP.&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt; There already are other responses in press and will be appearing&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt; soon.  This topic is also covered in my blog.  Click this&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;for more info (if you dare/care)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;a href="http://pharmacyinformatics.wordpress.com/?s=NUPOR"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;u&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#0000ff;"&gt;http://pharmacyinformatics.wordpress.com/?s=NUPOR&lt;/span&gt;&lt;/u&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/a&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;There is a link at the bottom of the article&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;’&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;s full text to submit a response the article.  I encourage you to do this whether you agree, disagree or have additional points to make.&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;  This is the AJHP&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;link&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;to send a&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;direct&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;response.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;a href="http://www.ajhp.org/cgi/eletter-submit/66/7/668"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;u&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#0000ff;"&gt;http://www.ajhp.org/cgi/eletter-submit/66/7/668&lt;/span&gt;&lt;/u&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/a&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;I look forward to hearing and viewing the res&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;p&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;onses.&lt;/span&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="ltr"&gt;&lt;span lang="en-us"&gt;&lt;span style="font-family:Verdana;font-size:85%;color:#000080;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com/"&gt;Posted via email&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/no-more-nupor-mooing-and-musin-0"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-861860110513173731?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/861860110513173731/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/no-more-nupor-mooing-and-musings-3.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/861860110513173731'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/861860110513173731'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/no-more-nupor-mooing-and-musings-3.html' title='No More NUPOR Mooing and Musings #3'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-5125616262277480837</id><published>2009-03-17T11:41:00.001-07:00</published><updated>2009-03-17T11:41:10.651-07:00</updated><title type='text'>
Two Very Different Views of eRx and EHR benefits  </title><content type='html'>&lt;br /&gt;&lt;font size="4"&gt;&lt;a href="http://govhealthit.com/articles/2009/03/16/eprescribing-saving.aspx"&gt;&lt;strong&gt;E-prescribing savings will offset the $19 billion feds will spend for health IT&lt;/strong&gt;&lt;/a&gt;&lt;/font&gt;&lt;br /&gt;  and&lt;br /&gt;&lt;a href="http://www.washingtonpost.com/wp-dyn/content/article/2009/03/16/AR2009031602618_pf.html"&gt;&lt;font size="+2"&gt;&lt;b&gt;Bad Bet on Medical Records&lt;/b&gt;&lt;/font&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;While not exactly apples to apples, example of the diverse opinions.  Mine is somewhere in the middle.  I do not think eRx will achieve this lofty goal.  The Washington Post editorial is a bit biased.  Not sure what the authors axe to grind is?&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via email&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/two-very-different-views-of-er"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-5125616262277480837?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/5125616262277480837/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/two-very-different-views-of-erx-and-ehr.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5125616262277480837'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5125616262277480837'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/two-very-different-views-of-erx-and-ehr.html' title='&#xA;Two Very Different Views of eRx and EHR benefits  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6340570503968124308</id><published>2009-03-16T11:01:00.001-07:00</published><updated>2009-03-16T11:01:50.198-07:00</updated><title type='text'>
Health Affairs March April 2009 Issue  </title><content type='html'>&lt;br /&gt;            &lt;p dir="LTR"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;The&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;/span&gt;&lt;a href="http://content.healthaffairs.org/content/vol28/issue2/"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;u&gt;&lt;font face="Verdana" size="2" color="#0000FF"&gt;latest issue of Health Affairs&lt;/font&gt;&lt;/u&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/a&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt; is packed full of content on health information technology from almost every angle.&amp;nbsp; This issue will keep me reading for some time.&amp;nbsp; There is a web site that has the&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;/span&gt;&lt;a href="http://www.healthaffairs.org/HIT/HIT_intro.php"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;u&gt;&lt;font face="Verdana" size="2" color="#0000FF"&gt;entire audio, video and powerpoints&lt;/font&gt;&lt;/u&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/a&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;font face="Verdana" size="2"&gt;from&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt; a briefing in Washington DC.&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;&amp;nbsp; Twitter has a&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;/span&gt;&lt;a href="http://search.twitter.com/search?q=%23hahit"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;u&gt;&lt;font face="Verdana" size="2" color="#0000FF"&gt;series of tweets&lt;/font&gt;&lt;/u&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/a&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt; done from the meeting that is&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;font face="Verdana" size="2"&gt;insightful&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;, especially if you read when viewing the&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;font face="Verdana" size="2"&gt;video;&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt; you get this&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;font face="Verdana" size="2"&gt;weird&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;font face="Verdana" size="2"&gt;virtual&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt; feel&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;ing&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt; of being there.&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;&amp;nbsp;&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;font face="Verdana" size="2"&gt;On&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;e&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt; of the articles&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;,&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;font face="Verdana" size="2"&gt;free to all&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;,&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt; called&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;/span&gt;&lt;a href="http://content.healthaffairs.org/cgi/content/abstract/28/2/361"&gt;&lt;span lang="en-us"&gt;&lt;u&gt;&lt;font color="#0000FF"&gt;Social Media In Health Care&lt;/font&gt;&lt;/u&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/a&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;font face="Verdana" size="2"&gt;is excellent.&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;/span&gt;&lt;/p&gt;    &lt;p dir="LTR"&gt;&lt;span lang="en-us"&gt;&lt;font face="Verdana" size="2"&gt;&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via email&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/health-affairs-march-april-200"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6340570503968124308?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6340570503968124308/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/health-affairs-march-april-2009-issue.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6340570503968124308'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6340570503968124308'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/health-affairs-march-april-2009-issue.html' title='&#xA;Health Affairs March April 2009 Issue  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-952502164072131265</id><published>2009-03-16T10:23:00.001-07:00</published><updated>2009-03-16T10:23:07.719-07:00</updated><title type='text'>
Getting Started on Twitter  </title><content type='html'>&lt;br /&gt;&lt;p&gt;&lt;span style="font-family: Verdana; color: navy; font-size: x-small;"&gt;&lt;span style="font-size: 10pt; color: navy; font-family: Verdana;"&gt;On  Twitter, for those that want to enter the &lt;span&gt;twitterverse&lt;/span&gt;, here is a suggestion.&lt;span&gt;&amp;nbsp; &lt;/span&gt;Following these people initially will help  you put your toe in the water (to better understand) without jumping in and  drowning.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;ul&gt;  &lt;li&gt;&lt;span style="font-family: Verdana; color: navy; font-size: x-small;"&gt;&lt;span style="font-size: 10pt; color: navy; font-family: Verdana;"&gt;&lt;a href="http://twitter.com/Berci" title="http://twitter.com/Berci"&gt;http://twitter.com/Berci&lt;/a&gt; Fascinating medical  student in Hungary, quickly becoming the first  Web 2.0 Medical superstar.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;  &lt;li&gt;&lt;span style="font-family: Verdana; color: navy; font-size: x-small;"&gt;&lt;span style="font-size: 10pt; color: navy; font-family: Verdana;"&gt;&lt;a href="http://twitter.com/kevinmd" title="http://twitter.com/kevinmd"&gt;http://twitter.com/kevinmd&lt;/a&gt; Kevin Pho, MD  from Nashua NH in primary care and winner of the best  medical blog of 2008.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;  &lt;li&gt;&lt;span style="font-family: Verdana; color: navy; font-size: x-small;"&gt;&lt;span style="font-size: 10pt; color: navy; font-family: Verdana;"&gt;&amp;nbsp;And  if you can stand it:&lt;a href="http://twitter.com/poikonen" title="http://twitter.com/poikonen"&gt;http://twitter.com/poikonen&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;  &lt;/ul&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via web&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/getting-started-on-twitter"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-952502164072131265?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/952502164072131265/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/getting-started-on-twitter_16.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/952502164072131265'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/952502164072131265'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/getting-started-on-twitter_16.html' title='&#xA;Getting Started on Twitter  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6805508075786770393</id><published>2009-03-16T10:04:00.001-07:00</published><updated>2009-03-16T10:04:57.698-07:00</updated><title type='text'>
50 Successful Open Source Projects That Are Changing Medicine  </title><content type='html'>&lt;br /&gt;&lt;div&gt;&lt;span style="font-family: Arial; font-size: 11px; "&gt;  &lt;div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "&gt;  &lt;div&gt;  &lt;blockquote&gt;  &lt;h1&gt;&lt;span style="font-size: small;"&gt;&lt;span style="font-weight: normal;"&gt;I have a new appreciation for Open Source projects, primarily through &lt;a href="http://www.lulu.com/content/paperback_book/after_the_software_wars/4964815?cid=en_home_featured_products"&gt;this book&lt;/a&gt; (currently free download). It seems to me that an Open Source project focused on medication clinical decision support is needed. &amp;nbsp;There will be more on this later as I am working with some others to develop this idea. &amp;nbsp;In the mean time this is a fantastic list of projects, fyi. &amp;nbsp;Found at&amp;nbsp;&lt;a href="http://nursingassistantguides.com/2009/50-successful-open-source-projects-that-are-changing-medicine/"&gt;http://nursingassistantguides.com/2009/50-successful-open-source-projects-that-are-changing-medicine/&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/h1&gt;  &lt;p&gt;&amp;nbsp;&lt;/p&gt;  &lt;/blockquote&gt;  &lt;h1&gt;50 Successful Open Source Projects That Are Changing Medicine&lt;/h1&gt;  &lt;p&gt;&lt;abbr title="2009-02-19"&gt;February 19, 2009&lt;/abbr&gt;&lt;/p&gt;  &lt;/div&gt;  &lt;div&gt;  &lt;p&gt;Open source healthcare is forging forward quickly on the Internet. But, fast developments often produce many failures. But, many medicinal open source projects that have gained success development. This success shows that open source alone is not the solitary factor in development. Instead, look to great management, public relations, marketing and a sound program that stands up under the scrutiny of a growing number of peer users and, often, patients.&lt;/p&gt;  &lt;p&gt;To limit this list to 50 projects means that we&amp;rsquo;ve tapped only the tip of the mountain of open source projects available to the healthcare industry. The following list is categorized alphabetically, and each link under every category is arranged alphabetically as well. We use this methodology to show that we do not favor one resource over another.&lt;/p&gt;  &lt;h3&gt;Ambulatory Care&lt;/h3&gt;  &lt;ol&gt;  &lt;li&gt;&lt;a href="http://www.clear-health.com/" title="Clear Health"&gt;ClearHealth&lt;/a&gt;: Medical software designed by clinics and hospitals and powered by Open Source software. ClearHealth includes modules for document storage, customizable reporting/forms, lab results and prescription management.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://egadss.sourceforge.net/" title="EGADSS"&gt;EGADSS&lt;/a&gt;: EGADSS is an open source tool that is designed to work in conjunction with primary care Electronic Medical Record (EMR) systems to provide patient specific point of care reminders in order to aid physicians provide high quality care.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.gnumed.org/" title="GNUmed"&gt;GNUmed&lt;/a&gt;: Use this free/open source software, released under the GNU Public license to andle your patient&amp;rsquo;s records.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.indivohealth.org/" title="Indivo Health"&gt;IndivoHealth&lt;/a&gt;: Indivo is a personally controlled health record system that enables patients to own complete, secure copies of their medical records.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.openehr.org/home.html" title="OpenEHR"&gt;OpenEHR&lt;/a&gt;: In the clinical space, it is about creating high-quality, re-usable clinical models of content and process - known as archetypes - along with formal interfaces to terminology. OpenEHR could take you there.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.oemr.org/" title="OpenEMR"&gt;OpenEMR&lt;/a&gt;: OpenEMR is a free medical practice management, electronic medical records, prescription writing, and medical billing application.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.openehr.org/home.html" title="OpenMRS"&gt;OpenMRS&lt;/a&gt;: OpenMRS is a community-developed, open-source, enterprise electronic medical record system framework.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.tolven.org/" title="Tolven"&gt;Tolven&lt;/a&gt;: An opportunity to use electronic Clinician Health Record (eCHR) and electronic Personal Health Record (ePHR) systems.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.uemr.com/" title="Ultimate EMR"&gt;Ultimate EMR&lt;/a&gt;: Ultimate EMR was designed as a Commercial Open Source application rich in features and that can be combined with many other products and tools.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://worldvista.org/World_VistA_EHR" title="Worldvista EHR"&gt;WorldVista EHR&lt;/a&gt;: WorldVistA EHR is an open source electronic health record based on the highly acclaimed VistA system of the United States Department of Veterans Affairs (VA).&lt;/li&gt;  &lt;/ol&gt;  &lt;h3&gt;Collaboration&lt;/h3&gt;  &lt;ol&gt;  &lt;li&gt;&lt;a href="http://www.gnu.org/licenses/license-list.html" title="GNU Projects"&gt;GNU Projects&lt;/a&gt;: The Free Software Foundation provides a variety of free and open source software and publishes a list of various open source licenses and comparative features.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://medsphere.org/index.jspa" title="Medsphere"&gt;Medsphere&lt;/a&gt;: Medsphere.org is a community gathering place where healthcare administrators, clinicians, developers and enthusiasts can interact, share, and collaborate.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://tech.groups.yahoo.com/group/openhealth/" title="Open Health"&gt;Open Health&lt;/a&gt;: This Yahoo! Group focuses on discussion of FOSS health I.T.-related topics.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.chirad.info/imiaoswg" title="Open Source Health Informatics Working Group"&gt;Open Source Health Informatics Working Group&lt;/a&gt;: IMIA OSWG brings together experts and interested individuals from a wide range of health professions and with a range of interests in the potential application of free/libre and open source solutions within their domains of expertise.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www2.amia.org/mbrcenter/wg/os/" title="OS-WG"&gt;OS-WG&lt;/a&gt;: The mission of the OS-WG (Open Source Working Group) is to act as the primary conduit between the broader open source community and AMIA (American Medical Informatics Association).&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.oshca.org/" title="OSHCA"&gt;OSHCA&lt;/a&gt;: OSHCA&amp;rsquo;s membership comprises a community of people, civil societies and professional bodies in health care and informatics industries that promotes the Free/Open Source Software Concepts in Health Care.&lt;/li&gt;  &lt;/ol&gt;  &lt;h3&gt;Integration&lt;/h3&gt;  &lt;ol&gt;  &lt;li&gt;&lt;a href="http://sourceforge.net/projects/gello/" title="Gello"&gt;Gello&lt;/a&gt;: ANSI-accredited HL7 standard for creating computable, unambiguous clinical queries.&lt;/li&gt;  &lt;li&gt;&lt;a href="https://www.i2b2.org/" title="i2b2"&gt;i2b2&lt;/a&gt;: i2b2 (Informatics for Integrating Biology and the Bedside) is an NIH-funded National Center for Biomedical Computing based at Partners HealthCare System. Their work is designed to facilitate the design of targeted therapies for individual patients with diseases having genetic origins.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://sourceforge.net/projects/iheos/" title="IHE Open Source"&gt;IHE Open Source&lt;/a&gt;: This project holds an implementation of the Cross-Enterprise Document Sharing (XDS) profile as defined by IHE (&lt;a href="http://ihe.net/"&gt;ihe.net&lt;/a&gt;).&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.mirthproject.org/" title="Mirth"&gt;Mirth&lt;/a&gt;: Mirth is an open source cross-platform HL7 interface engine that has established itself as the baseline for healthcare information exchange. Mirth allows messages to be filtered, transformed, and routed based on user-defined rules.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.recordsforliving.com/OpenHealthServices/" title="Records for Living"&gt;Records for Living&lt;/a&gt;: OpenHealth services allow for a wide variety of safe, secure reports and services to be delivered to consumers, leveraging the power of their electronic medical records.&lt;/li&gt;  &lt;/ol&gt;  &lt;h3&gt;Imaging/Visualization&lt;/h3&gt;  &lt;ol&gt;  &lt;li&gt;&lt;a href="http://neuroimage.usc.edu/brainstorm/" title="Brainstorm"&gt;BrainStorm&lt;/a&gt;: BrainStorm is an integrated free Matlab toolkit dedicated to Magnetoencephalography (MEG) and Electroencephalography (EEG) data visualization and processing.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.metk.net/" title="Medical Exploration Toolkit"&gt;Medical Exploration Toolkit&lt;/a&gt;: Advanced two- and three-dimensional visualizations with easy application building and efficient case management.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.microdicom.com/" title="Microdicom"&gt;MicroDicom&lt;/a&gt;: MicroDicom is application for primary processing and preservation of medical images in DICOM format.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://o3-rws+is+the+radiology+workstation+of+the+open+three+%28+o3+%29+consortium.+o3-rws+is+an+open+source,+ihe+based,+internationalized,+modular+and+portable+image+display./" title="O3-RWS"&gt;O3-RWS&lt;/a&gt;: O3-RWS is the Radiology Workstation of the Open Three (O3) Consortium. O3-RWS is an Open Source, IHE based, Internationalized, Modular and Portable Image Display.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://groups.google.com/group/medicalimagingscience/web/smiviewer-download-page?pli=1" title="SMIViewer"&gt;SMIViewer&lt;/a&gt;: A free (soon to be open source) DICOM volume analyzer for research/teaching on Windows.&lt;/li&gt;  &lt;/ol&gt;  &lt;h3&gt;Medical Practice Management Software&lt;/h3&gt;  &lt;ol&gt;  &lt;li&gt;&lt;a href="http://www.care2x.org/" title="CARE2X"&gt;CARE2X&lt;/a&gt;: Care2x integrates data, functions and workflows in a healthcare environment.&lt;/li&gt;  &lt;li&gt;&lt;a href="https://launchpad.net/ihris-suite" title="iHRIS Suite"&gt;iHRIS Suite&lt;/a&gt;: Open source HRIS solutions, distributed under the GPL, to supply health sector leaders and managers with the information they need to assess HR problems, plan effective interventions and evaluate those interventions.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.mirrormed.org/" title="MirrorMed"&gt;MirrorMed&lt;/a&gt;: MirrorMed is a free and open source EHR and practice management system written in PHP. This is a Web-based application that is capable of running a healthcare practice.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://open-dent.com/" title="Open Dental"&gt;OpenDental&lt;/a&gt;: Previously known as Free Dental, OpenDental is an open source Practice Management Software licensed under the GNU General Public License.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://tap-apps.sourceforge.net/" title="OpenTAPAS"&gt;OpenTAPAS&lt;/a&gt;: Technology Assisted Practice Application Suite (TAPAS) is a model to assist primary care physicians use technology in a targeted manner in their practices. It is an open source (GPL 2.0) collection of tools.&lt;/li&gt;  &lt;/ol&gt;  &lt;h3&gt;Online Publications&lt;/h3&gt;  &lt;ol&gt;  &lt;li&gt;&lt;a href="http://medicine.plosjournals.org/perlserv/?request=index-html&amp;amp;issn=1549-1676" title="PLos Medicine"&gt;PLos Medicine&lt;/a&gt;: A peer-reviewed open-access journal published by the Public Library of Science.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://linuxmednews.com/" title="LinuxMedNews"&gt;LinuxMedNews&lt;/a&gt;: This is your site for Linux, Free and Open Source medical software news, and has been since March 2000.&lt;/li&gt;  &lt;/ol&gt;  &lt;h3&gt;Programs&lt;/h3&gt;  &lt;ol&gt;  &lt;li&gt;&lt;a href="http://www.debian.org/devel/debian-med/" title="Debian Med"&gt;Debian Med&lt;/a&gt;: The goal of Debian Med is a complete system for all tasks in medical care which is built completely on free software.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.eclipse.org/ohf/" title="Eclipse"&gt;Eclipse Open Healthcare Framework (OHF) Project&lt;/a&gt;: The project is composed of extensible frameworks and tools which emphasize the use of existing and emerging standards in order to encourage interoperable open source infrastructure, thereby lowering integration barriers in healthcare informatics technology.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.cui.nhs.uk/" title="NHS"&gt;NHS&lt;/a&gt;: A UK NHS Interface (CUI), program guidance and product library available to NHS users and service providers using N3.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://od1n.sourceforge.net/index.html" title="ODIN"&gt;ODIN&lt;/a&gt;: ODIN is a C++ software framework to develop, simulate and run magnetic resonance sequences on different platforms.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://gnbts9.units.it/cmsO3/index.php?page=o3-rws" title="Open Three Consortium"&gt;Open Three (O3) Consortium&lt;/a&gt;: An innovative open-source project dealing with the multi-centric integration of hospitals, RHIOs and citizen (care at home and on the move, and ambient assisted living), based on the about 60 HECE bilateral cooperation Agreements with healthcare facilities. Use their imaging, collaboration and other software.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://www.opengalen.org/" title="Open Galen"&gt;OpenGalen&lt;/a&gt;: Their goal is to promote healthcare through stimulating the use and development of GALEN experience and technology as a basis for teaching, training and services in the area of medical terminology, language, knowledge and information and in anything directly or indirectly related in the widest sense.&lt;/li&gt;  &lt;/ol&gt;  &lt;h3&gt;Public Health and Biosurvellance&lt;/h3&gt;  &lt;ol&gt;  &lt;li&gt;&lt;a href="http://www.epispider.net/" title="EpiSPIDER"&gt;EpiSPIDER&lt;/a&gt;: This experimental map is generated from news reports from both expert-curated and general news sources on epidemics.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://sourceforge.net/projects/influsim" title="Influism"&gt;Influism&lt;/a&gt;: To be used for pandemic preparedness planning by health care offices, this download computes the effect of interventions like antiviral treatment of cases and social distancing.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://openemed.org/" title="OpenMed"&gt;OpenEMed&lt;/a&gt;: Biosurveillance and clinical data repository based on Web services and modules. Offers solid interoperability and federation of clinical data.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://openrods.sourceforge.net/" title="RODS"&gt;RODS&lt;/a&gt;: &amp;ldquo;Real-time Outbreak and Disease Surveillance&amp;rdquo; (RODS) is an open-source public health surveillance software.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://sispread.sourceforge.net/" title="Sispread"&gt;Sispread&lt;/a&gt;: This open source tool was created to help people concerned by public health to easily perform epidemic simulations and to analyze their results.&lt;/li&gt;  &lt;/ol&gt;  &lt;h3&gt;Software&lt;/h3&gt;  &lt;ol&gt;  &lt;li&gt;&lt;a href="http://hp2010.nhlbihin.net/atpiii/atp3palm.htm" title="ATP III Cholesterol Management"&gt;ATP III Cholesterol Management&lt;/a&gt;: This interactive guideline tool will assist the clinician in implementing the ATP III Cholesterol Guidelines at the point of care on a Palm OS.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://hp2010.nhlbihin.net/bmi_palm.htm" title="BMI Calculator"&gt;BMI Calculator&lt;/a&gt;&amp;nbsp;: This calculator runs on any device running the Palm Operating System (Palm OS) and PocketPC 2003.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://hp2010.nhlbihin.net/haac_palm/haac_palm.htm" title="Heart Attack Signs"&gt;Heart Attack Signs&lt;/a&gt;: This Palm OS program provides physicians and other health care providers talking points for discussing heart attack warning signs and survival steps with patients.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://ipath.sourceforge.net/" title="IPath"&gt;IPath&lt;/a&gt;&amp;nbsp;: iPath is an open source platform for telemedicine applications such as consultations, case discussions, virtual staff meetings and more.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://sourceforge.net/projects/medmapper/" title="MedMapper"&gt;MedMapper&lt;/a&gt;: Medical decision making algorithm tool. Visual design tool generates Tcl/Tk code. Non-programmers can design interactive algorithms. Generates notes for inclusion in medical record.&lt;/li&gt;  &lt;li&gt;&lt;a href="http://code.google.com/p/zephyropen/" title="Zephyropen"&gt;Zephyropen&lt;/a&gt;&amp;nbsp;: Open source SDK for health monitoring devices and downloads for OSX, PC and cell phones.&lt;/li&gt;  &lt;/ol&gt;&lt;/div&gt;  &lt;/div&gt;  &lt;/span&gt;&lt;/div&gt;  &lt;p&gt;&amp;nbsp;&lt;/p&gt;  &lt;div&gt;&lt;span style="border-collapse: separate; color: #000000; font-family: Helvetica; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0; "&gt;  &lt;div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "&gt;&lt;span style="border-collapse: separate; color: #000000; font-family: Helvetica; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; "&gt;  &lt;div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "&gt;&lt;span style="border-collapse: separate; color: #000000; font-family: Helvetica; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; "&gt;  &lt;div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "&gt;  &lt;div&gt;  &lt;div&gt;  &lt;div&gt;John Poikonen&lt;/div&gt;  &lt;div&gt;&lt;a href="mailto:john@poikonen.net"&gt;john@poikonen.net&lt;/a&gt;&lt;/div&gt;  &lt;div&gt;On Line&amp;nbsp;Presence&amp;nbsp;&lt;/div&gt;  &lt;div&gt;  &lt;div&gt;&lt;a href="http://twitter.com/poikonen"&gt;http://twitter.com/poikonen&lt;/a&gt;&lt;/div&gt;  &lt;div&gt;  &lt;div&gt;&lt;a href="http://pharmacyinformatics.wordpress.com"&gt;http://pharmacyinformatics.wordpress.com&lt;/a&gt;&lt;/div&gt;  &lt;div&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics"&gt;http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics&lt;/a&gt;&lt;/div&gt;  &lt;/div&gt;  &lt;/div&gt;  &lt;/div&gt;  &lt;/div&gt;  &lt;/div&gt;  &lt;/span&gt;&lt;/div&gt;  &lt;/span&gt;&lt;/div&gt;  &lt;/span&gt;&lt;/div&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via email&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/50-successful-open-source-proj"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6805508075786770393?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6805508075786770393/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/50-successful-open-source-projects-that.html#comment-form' title='4 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6805508075786770393'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6805508075786770393'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/50-successful-open-source-projects-that.html' title='&#xA;50 Successful Open Source Projects That Are Changing Medicine  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>4</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2505197833434616973</id><published>2009-03-16T09:49:00.001-07:00</published><updated>2009-03-16T09:49:17.052-07:00</updated><title type='text'>
Hospitals try ATM for drugs  </title><content type='html'>&lt;br /&gt;                                    &lt;div&gt;    &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;  font-family:Verdana"&gt;&amp;nbsp;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;    &lt;table cellspacing="0" border="0" cellpadding="0" style="border-collapse:collapse"&gt;  &lt;tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes"&gt;  &lt;td colspan="2" style="padding:.75pt .75pt .75pt .75pt"&gt;  &lt;p align="right" style="text-align:right"&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;&lt;a href="http://www.evernote.com/"&gt;&lt;font color="#891d02"&gt;&lt;span style="color:  #891D02;text-decoration:none;text-underline:none"&gt;&lt;p&gt;&lt;img src="http://posterous.com/getfile/files.posterous.com/poikonen/9e8Oo9XIMlgxn4MeXh4o72iZSlSHyajIEmqimPRzEs58tf0mpLKiEKNMl9ra/HTMLPack_SentFrom.gif" width="127" height="19"&gt;&lt;/p&gt; &lt;/span&gt;&lt;/font&gt;&lt;/a&gt;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;/td&gt;  &lt;/tr&gt;  &lt;tr style="mso-yfti-irow:1"&gt;  &lt;td bgcolor="#78BA43" valign="top" style="background:#78BA43;padding:0in 6.0pt 0in 6.0pt"&gt;  &lt;div style="margin-top:6.0pt;margin-bottom:4.5pt"&gt;  &lt;p&gt;&lt;b&gt;&lt;font face="Verdana" size="2" color="white"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana;color:white;font-weight:bold"&gt;&amp;nbsp;Hospitals  try ATM for drugs&amp;nbsp;&lt;/span&gt;&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;  &lt;/div&gt;  &lt;div style="margin-top:4.5pt;margin-bottom:4.5pt"&gt;  &lt;p&gt;&lt;font face="Verdana" size="1" color="white"&gt;&lt;span style="font-size:9.0pt;font-family:Verdana;color:white"&gt;&amp;nbsp;3/16/2009 11:46  AM&lt;span&gt;&amp;nbsp;&amp;nbsp;from &amp;nbsp;&lt;a href="http://www.nationalpost.com/story-printer.html?id=1393577"&gt;&lt;font color="white"&gt;&lt;span style="color:white"&gt;http://www.nationalpost.com/story-printer.html?id=1393577&lt;/span&gt;&lt;/font&gt;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;/div&gt;  &lt;/td&gt;  &lt;td bgcolor="#78BA43" valign="top" style="background:#78BA43;padding:0in 0in 0in 0in"&gt;  &lt;p align="right" style="text-align:right"&gt;&lt;font face="Verdana" size="2" color="white"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana;  color:white"&gt;&lt;p&gt;&lt;img src="http://posterous.com/getfile/files.posterous.com/poikonen/hTeirrAQclGk1fGYil9gMln8bF6weVfju4rHZmVaTL6H7jw28ml9ROInRSi6/HTMLPack_Curl.gif" width="44" height="52"&gt;&lt;/p&gt; &lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;/td&gt;  &lt;/tr&gt;  &lt;tr style="mso-yfti-irow:2"&gt;  &lt;td colspan="2" style="border:solid #78BA43 1.5pt;border-top:solid #78BA43 1.0pt;  mso-border-alt:solid #78BA43 1.5pt;mso-border-top-alt:solid #78BA43 .25pt;  padding:3.75pt 11.25pt 3.75pt 11.25pt"&gt;  &lt;div&gt;  &lt;h2&gt;&lt;b&gt;&lt;font face="Verdana" size="5"&gt;&lt;span style="font-size:18.0pt;font-family:  Verdana"&gt;Hospitals try ATM for drugs&lt;/span&gt;&lt;/font&gt;&lt;/b&gt;&lt;/h2&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Machine  connects to call centre to dispense pills&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;&lt;b&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;  font-family:Verdana"&gt;Tom Blackwell,&amp;nbsp; National Post&amp;nbsp;&lt;/span&gt;&lt;/font&gt;&lt;/b&gt;&lt;/strong&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;&lt;p&gt;&lt;img src="http://posterous.com/getfile/files.posterous.com/poikonen/m5iC1GhsdPFrBYkXI9Od3S9OwOmHUDJDHEKlCu0RrohoanhNUCJ39ZJmYNXg/1817218171_cde5d08050e1a837caa.jpg" width="194" height="131"&gt;&lt;/p&gt; Peter J. Thompson/National Post&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;div&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Hundreds  of Toronto  patients have been picking up their prescription drugs in recent months much  as they might withdraw cash or buy a can of soda -- from special vending  machines that some observers believe could transform the pharmacy business.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Customers  using the &lt;span&gt;PharmaTrust&lt;/span&gt; kiosks insert their prescription  into a slot and, a few minutes later, the device spits out their medication.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Skeptics  question whether the machines will ever duplicate the benefits of meeting in  person with a druggist. Proponents, though, say the Canadian-made invention,  which allows users to communicate with a real pharmacist by video link,  offers real convenience when there is no pharmacy open, or close by.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;&amp;quot;I  think it could be the next BlackBerry,&amp;quot; says Dr. Sharon &lt;span&gt;Domb&lt;/span&gt;, medical director of family medicine at Toronto's Sunnybrook Health  Sciences Centre, which has been testing the technology since last June.  &amp;quot;The feedback has been positive: 'It's great, it's fast, I don't have to  go anywhere else.' &amp;quot;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Another  hospital -- Cam-bridge Memorial in southwest Ontario  -- plans to install the machines in its emergency department next month,  while more are to be rolled out in a large, east-end Toronto doctor's office at about the same  time.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Some  pharmacists will undoubtedly feel threatened by the technology, says Jeff  Poston, executive director of the Canadian Pharmacists' Association.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;But  he predicts the machines will have only a niche role, likely in remote  communities that have limited pharmacy services, since the devices offer  patients a &amp;quot;lesser&amp;quot; form of communication with the druggist.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;&amp;quot;I  tend to think the face-to-face encounter with the pharmacist would win hands  down,&amp;quot; he said.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Yet  the notion of purchasing prescription medicine somewhat as one would buy a  bag of chips does not seem as jarring to many patients as it sounds.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Shelly  Dev, a long-time patient of Dr. &lt;span&gt;Domb's&lt;/span&gt; at  Sunnybrook, even suggests the machine's built-in telephone allows for a more  private conversation with the pharmacist, while the whole transaction is far  quicker than visiting a drugstore.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;She  used one of the dispensers for the first time on Friday to fill a  prescription for antibiotics, and was done in less than five minutes.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;&amp;quot;It's  very easy to use,&amp;quot; said Dr. Dev, who is an intensive-care physician at  Sunnybrook. &amp;quot;Usually, for most folks, you go see your physician ... you  leave, you go to another place to drop off your prescription, you have to go  back to pick it up. It's monotonous.&amp;quot;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;When  customers insert their prescription, the &lt;span&gt;ATMlike&lt;/span&gt;  machine -- made by PCA Services Inc. -- snaps high-resolution photographs of  both sides and transmits them to a pharmacist waiting in the firm's Oakville, Ont., &lt;span&gt;call&lt;/span&gt; centre.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;He  or she reads the information, directs the machine to start dispensing and  waits while robotic technology finds the prescribed medicine from among 340  different drugs stored inside. Once the pharmacist has verified the kiosk has  picked the right product, the machine pops out the order.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;During  the transaction, the customer speaks to the pharmacist via a telephone and  video screen built into the kiosk.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Just  over 800 patients used the machines at Sunnybrook to obtain 1,200  prescriptions between June and September. A survey of 108 of them indicated  that more than 95% received their drug in less than five minutes and would  use &lt;span&gt;PharmaTrust&lt;/span&gt; again, said Peter Suma, president  of PCA. None of the prescriptions was incorrectly filled, he said.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Not  everyone, however, was able to take advantage of the pharmaceutical ATMs.  About a third of patients who tried discovered that their medicine was not  available, said Dr. &lt;span&gt;Domb&lt;/span&gt;, though PCA offers to  deliver those orders to the patient's home the next day.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Despite  such limitations, Mr. Suma predicts his kiosks will be embraced by consumers  accustomed to instant, technologically aided service, especially when the  devices are &amp;quot;deployed ubiquitously.&amp;quot;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;&amp;quot;Although  this seems controversial now, I bet the telephone seemed controversial to the  guys who were delivering messages back then,&amp;quot; he said.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;And  steps are being taken in one province, at least, to allow much wider  distribution of the machines, which in Ontario  can be set up now only in hospitals and clinics.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;The  Ontario College of Pharmacists recommended last week the province change the  law to allow all &amp;quot;remote&amp;quot; dispensing-- whether it involves a  machine or a technician based in an isolated locale -- as long as a licensed  pharmacist oversees the transaction.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;&amp;quot;It  could be a very good thing, provided the safeguards for the public and  accountability are in place,&amp;quot; said Deanna Williams, the college's  registrar.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;The  financially strapped Cambridge  hospital will earn some revenue from the machines, but contracted with PCA  chiefly to offer convenience to emergency patients who show up 24 hours a  day, said Julia &lt;span&gt;Dumanian&lt;/span&gt;, the hospital's CEO.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Relatively  few pharmacies in the community are open late, let alone all night, she said.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;Meanwhile,  PCA is on the verge of striking deals with major clients in the United States and the United Kingdom.  In those cases, the company plans to partner with another organization, which  would run the call centre, much as RIM works with &lt;span&gt;cellphone&lt;/span&gt;  networks to provide Blackberry service, said Mr. Suma.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;  &lt;/div&gt;  &lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana"&gt;©  2009 The National Post Company. All rights reserved. Unauthorized  distribution, transmission or republication strictly prohibited.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;       &lt;div style='padding: 5px 5px 10px 5px; margin-top: 5px; border: 1px solid #ddd; background-color: #fff;line-height: 16px;'&gt;       &lt;div style="float: left; margin-right: 5px; overflow: visible;"&gt;&lt;a href='http://posterous.com/getfile/files.posterous.com/poikonen/XvrP23gqEuFCD0ZPECqh8v0l7AMkW2o4xAe0wy9eVa5Lc4idhLq3rdK17Fr3/Evernote.enex' style='color: #bc7134;'&gt;&lt;img src='http://posterous.com/images/filetypes/unknown.png' style='border: none;'/&gt;&lt;/a&gt;&lt;/div&gt;       &lt;div style="font-size: 10px; color: #424037;line-height: 16px;"&gt;Click here to download:&lt;/div&gt;       &lt;b&gt;&lt;a href='http://posterous.com/getfile/files.posterous.com/poikonen/XvrP23gqEuFCD0ZPECqh8v0l7AMkW2o4xAe0wy9eVa5Lc4idhLq3rdK17Fr3/Evernote.enex' style='color: #bc7134;'&gt;Evernote.enex&lt;/a&gt;&lt;/b&gt; &lt;span style="font-size: 10px; color: #424037;"&gt;(16 KB)&lt;/span&gt;       &lt;br style="clear: both;"/&gt;&lt;/div&gt;      &lt;/p&gt;&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via email&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/hospitals-try-atm-for-drugs-0"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2505197833434616973?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2505197833434616973/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/hospitals-try-atm-for-drugs.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2505197833434616973'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2505197833434616973'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/hospitals-try-atm-for-drugs.html' title='&#xA;Hospitals try ATM for drugs  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-3032051200610563376</id><published>2009-03-13T03:53:00.001-07:00</published><updated>2009-03-13T03:53:13.792-07:00</updated><title type='text'>
(NQF) has revised its list of practices that have proven effective in 	reducing adverse events - Pharmacy Informatics perspective  </title><content type='html'>&lt;br /&gt;The National Quality Forum (NQF) has revised its &lt;a href="http://www.qualityforum.org/publications/reports/safe_practices_2009.asp"&gt;list of practices&lt;/a&gt; that have &lt;b&gt;proven effective in reducing adverse events&lt;/b&gt;.  This is a very impressive list of practices.  It also revealing what is not on the list.&lt;br /&gt;  &lt;br /&gt;From a pure pharmacy informatics perspective the following practices are good to see.  CPOE and Pharmacy leadership are, of course, welcome additions to this list.  Using technology to enhance medication reconciliation and antimicrobial stewardship will go a long way to enhancing care as well and need a full court press by pharmacy and informatic departments.&lt;br /&gt;  &lt;br /&gt;Bar Code Medication Administration (BCMA) is not on the list.  This is not a big surprise.  I have settled into a role and view of a counter balance to most of my pharmacy colleagues.  There is a wide effort to implement BCMA to decrease adverse events without much evidence that it does anything.   Spouting a negative view on this practice is not comfortable nor one that I believe will last forever.  I fully believe that this practice will eventually be proven effective.  At this time it clearly is not.  Given this list of these proven practices, spending time and effort on BCMA if all of these practices are not fully exploted, may even be harmful.  We all have limited resources and time taken away from proven practices to ones of dubious value needs to be evaluated.&lt;br /&gt;  &lt;br /&gt;What say you?&lt;br /&gt;&lt;br /&gt;John Poikonen&lt;br /&gt;&lt;a href="mailto:john@poikonen.NET"&gt;john@poikonen.NET&lt;/a&gt;&lt;br /&gt;&lt;a href="http://twitter.com/poikonen"&gt;http://twitter.com/poikonen&lt;/a&gt;&lt;br /&gt;Blog = &lt;a href="http://pharmacyinformatics.wordpress.com/"&gt;http://pharmacyinformatics.wordpress.com/&lt;/a&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via email&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/nqf-has-revised-its-list-of-pr"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-3032051200610563376?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/3032051200610563376/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/nqf-has-revised-its-list-of-practices.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3032051200610563376'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3032051200610563376'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/nqf-has-revised-its-list-of-practices.html' title='&#xA;(NQF) has revised its list of practices that have proven effective in &#x9;reducing adverse events - Pharmacy Informatics perspective  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-8197733797737025193</id><published>2009-03-09T13:11:00.001-07:00</published><updated>2009-03-09T13:12:51.914-07:00</updated><title type='text'>‘No More NUPOR’ Mooing and Musing #2</title><content type='html'>&lt;p&gt;The original ‘No More NUPOR’ post is &lt;a href="http://pharmacyinformatics.wordpress.com/2009/03/07/no-more-nupor-near-universal-pharmacist-order-review/"&gt;here&lt;/a&gt;. To remind you - NUPOR is &lt;b&gt;N&lt;/b&gt;ear &lt;b&gt;U&lt;/b&gt;niversal &lt;b&gt;P&lt;/b&gt;harmacist &lt;b&gt;O&lt;/b&gt;rder &lt;b&gt;R&lt;/b&gt;eview, the current state of practice for medication orders. There is a group of informatics professionals that are questioning this scared cow. Here is the latest in what will be a series of commentaries on the subject. &lt;/p&gt;  &lt;p&gt;The following is a series of email conversations with some very high placed influential pharmacy leaders. Their names are not revealed as the points are more important than who said them. &lt;/p&gt;  &lt;p&gt;First this was noticed in the March 2009 Journal of Health System Pharmacy. &lt;/p&gt;  &lt;blockquote&gt;   &lt;p&gt;&lt;a href="http://www.ajhp.org/cgi/content/full/66/5_Supplement_3/s1"&gt;Executive Summary on the Global Conference for Hospital Pharmacy Practice&lt;/a&gt; (August 2008): “Optimally, all medicine orders should be reviewed by a pharmacist, but many countries do not have adequate resources to support this practice. Hospital pharmacists should assess which patients or patient care areas are in the greatest need of this service and then focus their order-review efforts on those patients or patient-care areas.”&lt;/p&gt; &lt;/blockquote&gt;  &lt;p&gt;This position more or less endorses the concept of NUPOR that is clearly not universally accepted, yet a standard of practice in the US. &lt;/p&gt;  &lt;p&gt;The next suggestion was that this statement&amp;#160; &lt;/p&gt;  &lt;blockquote&gt;   &lt;p&gt;“is essentially the &amp;quot;endorsed&amp;quot; preamble to (no more) NUPOR....” &lt;/p&gt; &lt;/blockquote&gt;  &lt;p&gt;Which was then noted that &lt;/p&gt;  &lt;blockquote&gt;   &lt;p&gt;“This is essentially the &lt;b&gt;internationally&lt;/b&gt; &amp;quot;endorsed&amp;quot; preamble to (no more) NUPOR....”&lt;/p&gt; &lt;/blockquote&gt;  &lt;p&gt;It occurred to me that some may take pot shots that the US is far better than most countries, to which I shot back (with out thinking beyond that) &lt;/p&gt;  &lt;blockquote&gt;   &lt;p&gt;“I can hear is now “what do those for-ners know’, we are better than that. That’s when you pull out this graph (below). [not from Michael Moore but a software biz plan]”&lt;/p&gt; &lt;/blockquote&gt;  &lt;p&gt;This is an amazing graph from a presentation at the &lt;a href="http://keas.com/links" target="_blank"&gt;2008 Connected Health Seminar at Harvard by Brian Bosworth founder of Keas, Inc.&lt;/a&gt; &lt;/p&gt;  &lt;p&gt;&lt;a href="http://lh4.ggpht.com/_B99sC3ffP3M/SbV33Rvl-eI/AAAAAAAAAUM/tBSdVbqk7FU/s1600-h/clip_image002%5B26%5D.jpg"&gt;&lt;img title="clip_image002" style="border-right: 0px; border-top: 0px; display: inline; margin-left: 0px; border-left: 0px; margin-right: 0px; border-bottom: 0px" height="311" alt="clip_image002" src="http://lh5.ggpht.com/_B99sC3ffP3M/SbV338goPDI/AAAAAAAAAUQ/3ffjHsqnjUI/clip_image002_thumb%5B23%5D.jpg?imgmax=800" width="402" border="0" /&gt;&lt;/a&gt;&lt;/p&gt;  &lt;p&gt;&amp;#160; &lt;/p&gt;  &lt;p&gt;Wouldn’t you know it? This was received within seconds: &lt;/p&gt;  &lt;blockquote&gt;   &lt;p&gt;“I attended and participated in the global conference in Basel and I also sit on the Joint Commission International (JCI) standards committee. I would caution any of you about looking at the statements from the conference or the JCI standards as something to which we should aspire in this country. For these groups the bar is set pretty low in order to establish a minimum baseline toward which to strive. For example, many countries don’t even have pharmacists in hospitals at this point in time – so I couldn’t even get the JCI committee to agree that a pharmacist should designated as being responsible for pharmacy services in hospitals.”&lt;/p&gt; &lt;/blockquote&gt;  &lt;p&gt;Clearly the person had not seen my post, so I thought I was going to be in big trouble.&amp;#160; I responded back: &lt;/p&gt;  &lt;blockquote&gt;   &lt;p&gt;Opps. I better qualify my previous email. My only point in the slide I sent (which strikes me as incredible) is that if Life Expectancy is a macro indicator of how well a health system does, then we suck and are paying way too much. A socialist view is that it is all insurance company greed and overhead, which, I admit is partly my view. Culture (mostly obesity) comes into it, so does delivery of pharmaceuticals. So, from a micro pharmacy view, looking at other countries health delivery systems need to be looked at and not dismissed out of hand.&lt;/p&gt; &lt;/blockquote&gt;  &lt;p&gt;Phew, dodged a bullet on that with the response &lt;/p&gt;  &lt;blockquote&gt;   &lt;p&gt;I agree 100% with you John that most of the money spent on healthcare in this country is a waste - and going to insurance executives, pharmaceutical companies, administrative overhead, bureaucratic BS and consultants. And individuals need to start taking responsibility for their own health – like all the third world countries. Then we would have much more money to give to GM!&lt;/p&gt;&lt;/blockquote&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-8197733797737025193?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/8197733797737025193/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/no-more-nupor-mooing-and-musing-2.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/8197733797737025193'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/8197733797737025193'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/no-more-nupor-mooing-and-musing-2.html' title='‘No More NUPOR’ Mooing and Musing #2'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://lh5.ggpht.com/_B99sC3ffP3M/SbV338goPDI/AAAAAAAAAUQ/3ffjHsqnjUI/s72-c/clip_image002_thumb%5B23%5D.jpg?imgmax=800' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-7178987582722244701</id><published>2009-03-09T11:47:00.001-07:00</published><updated>2009-03-09T11:47:52.739-07:00</updated><title type='text'>
No more NUPOR Mooing and Musings #1  </title><content type='html'>&lt;br /&gt;            &lt;p dir="LTR"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Calibri"&gt;F&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Calibri"&gt;rom the&lt;/font&gt;&lt;/span&gt;&lt;span lang="en-us"&gt; &lt;/span&gt;&lt;a href="http://www.ajhp.org/cgi/content/full/66/5_Supplement_3/s1"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;u&gt;&lt;font face="Calibri" color="#0000FF"&gt;Executive Summary on the Global Conference for Hospital Pharmacy Practice&lt;/font&gt;&lt;/u&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/a&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;span lang="en-us"&gt;&lt;font face="Calibri"&gt; (August 2008):&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="LTR"&gt;&lt;span lang="en-us"&gt;&lt;font face="Calibri"&gt;&amp;#8220;Optimally, all medicine orders should be reviewed by a pharmacist , but many countries do not have adequate resources to support this practice. Hospital pharmacists should assess which patients or patient care areas are in the greatest need of this service and then focus their order-review efforts on those patients or patient-care areas.&amp;#8221;&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;    &lt;p dir="LTR"&gt;&lt;span lang="en-us"&gt;&lt;/span&gt;&lt;/p&gt;        &lt;i&gt;The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material.  Any review, transmission, re-transmission, dissemination or other use of, or taking of any action in reliance upon this information by persons or entities other than the intended recipient is prohibited.  If you received this in error, please contact the sender and delete the material from any computer.&lt;/i&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via email&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/no-more-nupor-mooing-and-musin"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-7178987582722244701?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/7178987582722244701/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/no-more-nupor-mooing-and-musings-1.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/7178987582722244701'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/7178987582722244701'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/no-more-nupor-mooing-and-musings-1.html' title='&#xA;No more NUPOR Mooing and Musings #1  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6951702092057185169</id><published>2009-03-07T12:03:00.001-08:00</published><updated>2009-03-07T12:03:48.681-08:00</updated><title type='text'>
No More NUPOR - Near Universal Pharmacist Order Review  </title><content type='html'>&lt;br /&gt;&lt;p&gt;The concept of studing the possibility to eliminate NUPOR with better computerized clinical decision support originated with Allen Flynn, pharmacist informatics guru at Univ of Michigan Medical Center.&amp;nbsp; He will have a brilliant commentary in the &lt;a href="http://ajhp.org/"&gt;Am Journal of Health System Pharmacy&lt;/a&gt; in the April 1, 2009 issue.&amp;nbsp; I will have a follow up in the April 15th issue and Dennis Tribble, CTO/CPO, ForHealth Technologies will have a subsequent letter on the subject in the May or June time frame.&lt;br /&gt;&lt;br /&gt;The basic premise is that we need to study the impact of mandating near universal pharmacist order review on patient care and the profession.&amp;nbsp; If computerized clinical decision support can do some part or segment of order review as good or better than pharmacists, then that will free pharmacists to do more beneficial services for patients.&amp;nbsp; The AJHP commentaries will explore this in some depth.&amp;nbsp;&amp;nbsp; I encourage all to read and comment on this revolutionary topic.&amp;nbsp; Please comment directly in the new AJHP response system on the AJHP.org site that is below the articles.&amp;nbsp; Of course I welcome comments to this blog, but that will have wider exposure (for now, at least).&lt;br /&gt;&lt;br /&gt;At a speech by Robert Wachter of the great blog &lt;a href="http://www.the-hospitalist.org/blogs/default.aspx"&gt;Wacher&amp;rsquo;s World&lt;/a&gt; he indicated that when you gore sacred cows, expect a lot of Mooing.&amp;nbsp; NUPOR is a pharmacy sacred cow.&amp;nbsp; From time to time I will be posting the various Mooing and Musings on this topic.&amp;nbsp; I welcome your comments as this plays out, which I suspect might be a number of years.&lt;br /&gt;&lt;br /&gt;John Poikonen, PharmD&lt;/p&gt;&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via web&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/no-more-nupor-near-universal-p"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6951702092057185169?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6951702092057185169/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/no-more-nupor-near-universal-pharmacist.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6951702092057185169'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6951702092057185169'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/no-more-nupor-near-universal-pharmacist.html' title='&#xA;No More NUPOR - Near Universal Pharmacist Order Review  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4851422863081681299</id><published>2009-03-07T10:13:00.001-08:00</published><updated>2009-03-07T10:13:45.957-08:00</updated><title type='text'>
Checking out the amazing service Posterous.com  </title><content type='html'>&lt;br /&gt;This service will post via emails or SMS text to Twitter and Blogs automatically.&lt;br /&gt;See this for more info.  &lt;a href="http://www.posterous.com/faq/" target="_blank"&gt;http://www.posterous.com/faq/&lt;/a&gt; &lt;br /&gt;Very intriguing.  Single email will post to everything.&lt;p style="font-size: 10px;"&gt;  &lt;a href="http://posterous.com"&gt;Posted via email&lt;/a&gt;   from &lt;a href="http://poikonen.posterous.com/checking-out-the-amazing-servi-0"&gt;poikonen's posterous&lt;/a&gt;  &lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4851422863081681299?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4851422863081681299/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/checking-out-amazing-service.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4851422863081681299'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4851422863081681299'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/checking-out-amazing-service.html' title='&#xA;Checking out the amazing service Posterous.com  '/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6494260068002482376</id><published>2009-03-05T04:59:00.000-08:00</published><updated>2009-03-05T05:03:23.688-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacy'/><title type='text'>Nancy-Ann DeParle</title><content type='html'>&lt;p&gt;Here is one ray of hope for transformative change in healthcare. Nancy-Ann DeParle has been tapped to head the White House Health Care transition plan. She has been on some company boards that provide some insight that is positive. Presumably she 'gets' pharmacy (Medco), Health IT (Cerner) and Boston (Boston Scientific). Ok, that last one is a stretch.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;I had the pleasure to shadow the CEO of Cerner a while ago. If he is anything, he is passionate on the impact technology can and should have on health care. She would not be on the board unless she was totally committed to the use of technology to improve health.&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;As an aside, the Cerner CEO is a rapid Republican. His wife even ran for Congress but lost b/c she was way to the right of most rational mortals. So I love it that a (soon to be former) board member will be part of the Obama Administration.&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;http://www.nytimes.com/2009/03.../03health.html?_r=2&amp;amp;hp&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;blockquote&gt;&lt;br /&gt;  &lt;p&gt;Ms. DeParle has extensive experience in the business world that has prompted questions from some liberals and from some of the people who vet appointments for Mr. Obama. Ms DeParle is now or has been a director of huge health care companies including Medco Health Solutions, a pharmacy benefit manager; Cerner, a supplier of health information technology; Boston Scientific, a medical device company; DaVita, which runs kidney dialysis centers; and Triad Hospitals.&lt;/p&gt;&lt;br /&gt;&lt;/blockquote&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6494260068002482376?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6494260068002482376/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/nancy-ann-deparle.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6494260068002482376'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6494260068002482376'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/03/nancy-ann-deparle.html' title='Nancy-Ann DeParle'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6436546935823237123</id><published>2009-02-18T18:03:00.000-08:00</published><updated>2009-02-18T18:04:58.858-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Uncategorized'/><category scheme='http://www.blogger.com/atom/ns#' term='web2.0'/><title type='text'>http://medpedia.com/</title><content type='html'>&lt;p&gt;YIPPEE. worth checking out.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;Your credentials have been verified and you have been granted Editor privileges on Medpedia. You may now directly edit the Article pages of the collaborative encyclopedia.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;The goal of the Medpedia project is to create a new model of how the world will assemble, maintain, critique and access medical knowledge. The repository of up-to-date, unbiased medical information will be written and maintained by health experts like you, and will be freely available to everyone.&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;As an Editor, you will receive permanent, public recognition for your contributions to this transformational project.&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;Please click the link below to begin developing your presence in Medpedia by adding to and editing the Articles in your areas of expertise&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;http://medpedia.com/&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;Welcome,&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;The Medpedia Project&lt;/p&gt;&lt;br /&gt;&lt;p&gt;-------&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p&gt;Medpedia - a new model for sharing and advancing knowledge about health, medicine and the body.&lt;/p&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6436546935823237123?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6436546935823237123/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/httpmedpediacom.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6436546935823237123'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6436546935823237123'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/httpmedpediacom.html' title='http://medpedia.com/'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-8296839500442881977</id><published>2009-02-17T07:47:00.001-08:00</published><updated>2009-02-17T07:47:10.434-08:00</updated><title type='text'>Penicillin Allergies</title><content type='html'>&lt;p&gt;Here is a really interesting study, per Jim Carpenter in Portland, on a &lt;a href="http://www.annemergmed.com/webfiles/images/journals/ymem/asraja.pdf" target="_blank"&gt;very high documented true allergy rate of self reported Penicillin allergies in a ED&lt;/a&gt;.&amp;#160; 91% of people that stated a PCN allergy did not have a IgE mediated response.&amp;#160; Wow, that sounds high to me.&amp;#160; &lt;/p&gt;  &lt;p&gt;As Jim points out in his Twitter post, this may have significant implications for CDS alerting.&amp;#160; Some logic based on the patients condition and infection where a PCN or Cephalosporin may be the best choice might invoke a suggestion to do a skin test to determine if a true allergy exists.&amp;#160;&amp;#160; The article has a table of potential cost savings.&lt;/p&gt;  &lt;p&gt;&lt;a title="http://www.annemergmed.com/webfiles/images/journals/ymem/asraja.pdf" href="http://www.annemergmed.com/webfiles/images/journals/ymem/asraja.pdf"&gt;http://www.annemergmed.com/webfiles/images/journals/ymem/asraja.pdf&lt;/a&gt;&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-8296839500442881977?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/8296839500442881977/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/penicillin-allergies.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/8296839500442881977'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/8296839500442881977'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/penicillin-allergies.html' title='Penicillin Allergies'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6203220977898501787</id><published>2009-02-16T07:40:00.001-08:00</published><updated>2009-02-16T07:47:59.131-08:00</updated><title type='text'>How Twitter Changed by Life</title><content type='html'>&lt;div style="width: 425px; text-align: left;" id="__ss_944343"&gt;Ok, this might be a stretch, my life has not changed all that much, but Twitter is fascinating. This slide show posted by Berci, famous for all things Medicine 2.0 is useful to introduce you to Twitter. btw my name on Twitter is "poikonen" -jp&lt;br /&gt;&lt;br /&gt;http://scienceroll.com/2009/02/14/how-twitter-changed-my-life-slideshow/&lt;br /&gt;&lt;br /&gt;&lt;a style="margin: 12px 0pt 3px; font-family: Helvetica,Arial,Sans-serif; font-style: normal; font-variant: normal; font-weight: normal; font-size: 14px; line-height: normal; font-size-adjust: none; font-stretch: normal; display: block; text-decoration: underline;" href="http://www.slideshare.net/minxuan/how-twitter-changed-my-life-presentation?type=presentation" title="How Twitter Changed My Life"&gt;How Twitter Changed My Life&lt;/a&gt;&lt;object style="margin: 0px;" height="355" width="425"&gt;&lt;param name="movie" value="http://static.slideshare.net/swf/ssplayer2.swf?doc=howtwitterchangedmylife-1232669432028989-1&amp;amp;stripped_title=how-twitter-changed-my-life-presentation"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;param name="allowScriptAccess" value="always"&gt;&lt;embed src="http://static.slideshare.net/swf/ssplayer2.swf?doc=howtwitterchangedmylife-1232669432028989-1&amp;amp;stripped_title=how-twitter-changed-my-life-presentation" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" height="355" width="425"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;div style="font-size: 11px; font-family: tahoma,arial; height: 26px; padding-top: 2px;"&gt;View more &lt;a style="text-decoration: underline;" href="http://www.slideshare.net/"&gt;presentations&lt;/a&gt; from &lt;a style="text-decoration: underline;" href="http://www.slideshare.net/minxuan"&gt;Minxuan Lee&lt;/a&gt;. (tags: &lt;a style="text-decoration: underline;" href="http://slideshare.net/tag/micro"&gt;micro&lt;/a&gt; &lt;a style="text-decoration: underline;" href="http://slideshare.net/tag/twitter"&gt;twitter&lt;/a&gt;)&lt;/div&gt;&lt;/div&gt;&lt;img style="visibility: hidden; width: 0px; height: 0px;" src="http://counters.gigya.com/wildfire/IMP/CXNID=2000002.0NXC/bHQ9MTIzNDc5ODE1NjY1NCZwdD*xMjM*Nzk4ODQyMzUwJnA9MTAxOTEmZD*mbj1ibG9nZ2VyJmc9MiZ*PSZvPTU4MzQyY2FhNWU2NzQwZWFiODIyZTlkZGYzYWI1ZjNi.gif" border="0" height="0" width="0" /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6203220977898501787?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6203220977898501787/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/how-twitter-changed-by-life.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6203220977898501787'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6203220977898501787'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/how-twitter-changed-by-life.html' title='How Twitter Changed by Life'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-8805651208444425485</id><published>2009-02-11T03:42:00.001-08:00</published><updated>2009-02-11T03:42:32.418-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='cds'/><category scheme='http://www.blogger.com/atom/ns#' term='DDI'/><category scheme='http://www.blogger.com/atom/ns#' term='allergies'/><category scheme='http://www.blogger.com/atom/ns#' term='CPOE'/><title type='text'>Clinicians Ignore most eRx Alerts</title><content type='html'>&lt;p&gt;&lt;/p&gt;&lt;div&gt;&lt;div class="ennote"&gt;What in medicine do we tolerance 90%+ false positive rates, without getting rid of it?&lt;br /&gt;We have a long way to go in CDS.&amp;nbsp; Below is from a ASHP press release on a new Archives of IM study, recommended read.&lt;br /&gt;-jp&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Clinicians Ignore Most e-Prescribing Alerts&lt;br /&gt;Kate Traynor&lt;br /&gt;&lt;p&gt;BETHESDA, MD 09 February 2009—A large study of electronic prescribing in the outpatient setting suggests that prescribers override most warnings that indicate a medication allergy or drug interaction, according to a&amp;nbsp;&lt;a shape="rect" href="http://archinte.ama-assn.org/cgi/content/short/169/3/305" target="_blank"&gt;report&lt;/a&gt; in the February 9 Archives of Internal Medicine.&lt;/p&gt;The analysis of data for 2872 prescribers in Massachusetts, New Jersey, and Pennsylvania over a nine-month period in 2006 found that the clinicians accepted 23% of alerts for medication allergies and 9.2% of drug interaction alerts. Alerts were almost always ignored for medications that had been previously prescribed for the patient. &lt;br /&gt;  &lt;p&gt;The study examined more than 3 million electronic prescriptions generated using Zix Corporation's PocketScript program. Of these, about 6.6% resulted in an interaction alert to the prescriber. Less than 2% of the alerts were for medication allergies; the rest informed the clinician that the selected medication potentially interacts with another drug currently taken by the patient. &lt;/p&gt;Drug interactions were classified in the prescribing program as low, medium, or high severity, and the severity level was displayed on the prescribing device's screen. About 62% of the alerts in the study were classified as high severity, and 29% were of medium severity. High-severity alerts were overridden about 90% of the time, and lower-level alerts were disregarded about 93% of the time. &lt;br /&gt;  &lt;p&gt;According to the report, PocketScript's severity classifications are produced by pharmacists at a health information technology company. The report's authors suggested that reexamining and reclassifying some of the high-severity alerts, particularly those that are most often overridden, may increase prescribers' acceptance of drug-interaction warnings. &lt;/p&gt;Prescribers took some high-severity drug–drug interactions more seriously than others. For example, warnings not to use noncardioselective beta-blockers and macrolides together were accepted 43.1% of the time. &lt;br /&gt;  &lt;p&gt;The next-most-commonl...&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics#2a3d72b6-ceb8-418d-b30a-e9dcc4b2fff3"&gt;View Original Article&lt;/a&gt;&lt;/p&gt;&lt;div class="flockcredit" style="text-align: right; color: #CCC; font-size: x-small;"&gt;Blogged with the &lt;a href="http://www.flock.com/blogged-with-flock" style="color: #999; font-weight: bold;" target="_new" title="Flock Browser"&gt;Flock Browser&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-8805651208444425485?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/8805651208444425485/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/clinicians-ignore-most-erx-alerts.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/8805651208444425485'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/8805651208444425485'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/clinicians-ignore-most-erx-alerts.html' title='Clinicians Ignore most eRx Alerts'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2181800327843831256</id><published>2009-02-10T06:29:00.001-08:00</published><updated>2009-02-10T06:29:13.937-08:00</updated><title type='text'>More on the BCMA AHRQ Report</title><content type='html'>&lt;p&gt;I commented on a &lt;a href="http://healthit.ahrq.gov/images/dec08bcmareport/bcma_issue_paper.htm" target="_blank"&gt;report by AHRQ on BCMA&lt;/a&gt; already in &lt;a href="http://pharmacyinformatics.blogspot.com/2009/02/medication-errors-occurring-with-use-of.html" target="_blank"&gt;this post&lt;/a&gt;.&amp;#160; It does nothing to bolster the BCMA evidence. &lt;/p&gt;  &lt;p&gt;Now on further examination the references are even more embarrassing than first thought.&amp;#160; Thanks to Brent Fox at Auburn that noticed this.&amp;#160; Check these sets of references in the report:&lt;/p&gt;  &lt;ul&gt;   &lt;li&gt;2, 16, 26 &lt;/li&gt;    &lt;li&gt;6 and 27 &lt;/li&gt;    &lt;li&gt;8 and 18 &lt;/li&gt;    &lt;li&gt;9 and 19 &lt;/li&gt;    &lt;li&gt;10 and 20 &lt;/li&gt;    &lt;li&gt;11 and 21 &lt;/li&gt;    &lt;li&gt;12 and 22 &lt;/li&gt;    &lt;li&gt;13, 14, 23, 24 &lt;/li&gt; &lt;/ul&gt;  &lt;p&gt;Must be getting paid by the references.&amp;#160; More references = more credibility? Not.&amp;#160; Very disappointing from AHRQ, whose publications are usually first rate.&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2181800327843831256?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2181800327843831256/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/more-on-bcma-ahrq-report.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2181800327843831256'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2181800327843831256'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/more-on-bcma-ahrq-report.html' title='More on the BCMA AHRQ Report'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2958577508447896376</id><published>2009-02-05T05:56:00.001-08:00</published><updated>2009-02-05T05:56:29.752-08:00</updated><title type='text'>Patient Safety and a Tale of Two Pilots: US Airway’s Sullenberger and KLM’s Van Zanten</title><content type='html'>&lt;p&gt;&lt;/p&gt;&lt;div&gt;When a New York policeman commandeered a chopper after receiving a “plane down” distress call, he expected to find a Cessna or a Piper in the river. “I never, in a million years, expected to see US Airways in the Hudson,” said Sgt. Michael Hendrix when...(&lt;a href="http://www.the-hospitalist.org/blogs/wachters_world/archive/2009/01/17/patient-safety-and-a-tale-of-two-pilots-usairway-s-sullenberger-and-klm-s-van-zanten.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.the-hospitalist.org/aggbug.aspx?PostID=513" width="1" height="1" /&gt;&lt;/div&gt;&lt;p&gt;&lt;a href="http://www.the-hospitalist.org/blogs/wachters_world/archive/2009/01/17/patient-safety-and-a-tale-of-two-pilots-usairway-s-sullenberger-and-klm-s-van-zanten.aspx"&gt;View Original Article&lt;/a&gt;&lt;/p&gt;&lt;div class="flockcredit" style="text-align: right; color: #CCC; font-size: x-small;"&gt;Blogged with the &lt;a href="http://www.flock.com/blogged-with-flock" style="color: #999; font-weight: bold;" target="_new" title="Flock Browser"&gt;Flock Browser&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2958577508447896376?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2958577508447896376/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/patient-safety-and-tale-of-two-pilots.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2958577508447896376'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2958577508447896376'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/patient-safety-and-tale-of-two-pilots.html' title='Patient Safety and a Tale of Two Pilots: US Airway’s Sullenberger and KLM’s Van Zanten'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-1869211467980134483</id><published>2009-02-03T07:30:00.001-08:00</published><updated>2009-02-03T07:30:31.147-08:00</updated><title type='text'>AJHP versus NEJM</title><content type='html'>&lt;a href="http://efficientmd.blogspot.com/2008/10/twitter-dispatches-from-new-england.html"&gt;The Efficient MD - Life Hacks for Healthcare: Twitter Dispatches from the New England Journal of Medicine's Horizons Conference&lt;/a&gt; &lt;br /&gt;&lt;br /&gt;&lt;meta http-equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 11"&gt;&lt;meta name="Originator" content="Microsoft Word 11"&gt;&lt;link rel="File-List" href="file:///C:%5CDOCUME%7E1%5Cpoikonej%5CLOCALS%7E1%5CTemp%5Cmsohtml1%5C01%5Cclip_filelist.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:WordDocument&gt;  &lt;w:View&gt;Normal&lt;/w:View&gt;  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;  &lt;w:PunctuationKerning/&gt;  &lt;w:ValidateAgainstSchemas/&gt;  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;  &lt;w:Compatibility&gt;   &lt;w:BreakWrappedTables/&gt;   &lt;w:SnapToGridInCell/&gt;   &lt;w:WrapTextWithPunct/&gt;   &lt;w:UseAsianBreakRules/&gt;   &lt;w:DontGrowAutofit/&gt;  &lt;/w:Compatibility&gt;  &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt; &lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:LatentStyles DefLockedState="false" LatentStyleCount="156"&gt; &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!-- /* Font Definitions */ @font-face 	{font-family:Verdana; 	panose-1:2 11 6 4 3 5 4 4 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:536871559 0 0 0 415 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-parent:""; 	margin:0in; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman";} a:link, span.MsoHyperlink 	{color:blue; 	text-decoration:underline; 	text-underline:single;} a:visited, span.MsoHyperlinkFollowed 	{color:purple; 	text-decoration:underline; 	text-underline:single;} span.EmailStyle16 	{mso-style-type:personal; 	mso-style-noshow:yes; 	mso-ansi-font-size:10.0pt; 	mso-bidi-font-size:10.0pt; 	font-family:Verdana; 	mso-ascii-font-family:Verdana; 	mso-hansi-font-family:Verdana; 	mso-bidi-font-family:Arial; 	color:windowtext;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt; /* Style Definitions */ table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin:0in; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:10.0pt; 	font-family:"Times New Roman"; 	mso-ansi-language:#0400; 	mso-fareast-language:#0400; 	mso-bidi-language:#0400;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Verdana;"&gt;I happened on &lt;a href="http://efficientmd.blogspot.com/"&gt;this blog&lt;/a&gt; that is very interesting.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;&lt;a href="http://efficientmd.blogspot.com/2008/10/twitter-dispatches-from-new-england.html"&gt;This post&lt;/a&gt; on what the NEJM is doing, struck me as something AJHP might consider.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Verdana;"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Verdana;"&gt;This initiative by NEJM is outstanding.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;Clearly they are skating to where the puck is being shot, not to where it is now.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Verdana;"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Verdana;"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 0.5in;"&gt;The &lt;em&gt;New England Journal of Medicine&lt;/em&gt; is seeking to bring together a group of visionary medical students and trainees to help &lt;a href="http://www.nejm.org/" title="New England Journal of Medicine"&gt;NEJM&lt;/a&gt; &lt;b style=""&gt;push the boundaries of traditional medical publishing.&lt;/b&gt; We are looking for creative minds to join the editors for a weekend to explore what's possible. We anticipate a vigorous dialogue around the ideas that invited participants and other speakers share with the group.&lt;o:p&gt;&lt;/o:p&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;Twitter feed of the conference&lt;o:p&gt;&lt;/o:p&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Verdana;"&gt;&lt;a href="http://search.twitter.com/search?max_id=1172796326&amp;amp;page=1&amp;amp;q=%23NEJM"&gt;http://search.twitter.com/search?max_id=1172796326&amp;amp;page=1&amp;amp;q=%23NEJM&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Verdana;"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;span style="font-size: 10pt; font-family: Verdana;"&gt;My bias and unfounded perception is that AJHP is stuck in the mud a bit.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;Part of this bias is the (weird) push back I have gotten on the Green Initiative passed by the HoD; right or wrong.&lt;span style=""&gt;&amp;nbsp; &lt;/span&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-1869211467980134483?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/1869211467980134483/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/ajhp-versus-nejm.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1869211467980134483'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1869211467980134483'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/ajhp-versus-nejm.html' title='AJHP versus NEJM'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-5009596431445039802</id><published>2009-02-02T14:15:00.001-08:00</published><updated>2009-02-02T14:15:32.288-08:00</updated><title type='text'>Medication Errors Occurring with the Use of Bar-Code Administration Technology</title><content type='html'>&lt;p&gt;Below is a very nice article on how to overcome workarounds and process improvement. &lt;/p&gt;  &lt;p&gt;My 'beef' with this and many other bar code studies is that it assumes that BCMA is a good thing. This is a false assumption. &lt;/p&gt;  &lt;p&gt;The studies and references in this paper do not support the benefit statements. &lt;/p&gt;  &lt;blockquote&gt;   &lt;p&gt;&amp;quot;Studies have shown that BCMA can reduce medication errors by 65% to 86%. 5,6,7 &amp;quot;&lt;/p&gt;    &lt;ul&gt;     &lt;li&gt;*Reference 5 is a HIMSS presentation (no peer review) &lt;/li&gt;      &lt;li&gt;*Reference 6 is pure speculation piece in AJHP (no science) &lt;/li&gt;      &lt;li&gt;*Reference 7 is based on reportable errors. What if folks where so busy or ticked off that they did not report errors, post implementations. The author of this reference even has communicated to me that this study was never intended to be used as evidence for showing decrease errors. &lt;/li&gt;   &lt;/ul&gt; &lt;/blockquote&gt;  &lt;blockquote&gt;   &lt;p&gt;Also: &amp;quot;one hospital in Pennsylvania showed that the direct-observation accuracy rate before BCMA was 86.5%; after BCMA, the rate rose to 97%.8&amp;quot; &lt;/p&gt;    &lt;ul&gt;     &lt;li&gt;*This reference is a post study from complete manual to full eMAR and BCMA. What if 99% of the benefit was with eMAR and not bar coding? &lt;/li&gt;   &lt;/ul&gt; &lt;/blockquote&gt;  &lt;p&gt;&lt;a href="http://patientsafetyauthority.org/ADVISORIES/AdvisoryLibrary/2008/Dec5(4)/Pages/122.aspx" target="_blank"&gt;Medication Errors Occurring with the Use of Bar-Code Administration Technology&lt;/a&gt; - &lt;em&gt;&lt;/em&gt;&lt;/p&gt;  &lt;div class="ennote"&gt;   &lt;div&gt;Medication Errors Occurring with the Use of Bar-Code Administration Technology&lt;/div&gt;    &lt;div&gt;Pa Patient Saf Advis 2008 Dec;5(4):122-6.&lt;/div&gt;    &lt;p&gt;&lt;a shape="rect" name="bm1"&gt;Abstract&lt;/a&gt;&lt;/p&gt;    &lt;p&gt;Bar-code medication administration (BCMA) systems can improve medication safety by verifying that the right drug is being administered to the right patient. Studies have shown that BCMA technology can reduce medication errors by 65% to 86%. But BCMA technology alone does not ensure a safe medication-use system. A number of reports submitted through PA-PSRS describe medication errors that occurred in organizations that used a bar-code system for administration. Some of these errors result from failures to use this technology appropriately, employing workarounds or overriding alerts, disruptions in the medication administration process, and dispensing errors that arise in the pharmacy. Strategies to address problems with this technology include reviewing BCMA logs to evaluate overrides and identify system weaknesses and monitoring and measuring compliance with the technology to identify and remove any barriers to its appropriate use.&lt;/p&gt;    &lt;p&gt;A prospective cohort study of medication errors by Leape et al.1 determined that 39% of errors occurred during the prescribing phase, 12% during transcription, 11% during dispensing, and 38% during administration. Close to half of the errors that occurred during the prescribing phase were intercepted before they reached the patient; in contrast, only 2% of errors that occurred during the administration phase were intercepted. Another study using direct observation in 36 healthcare facilities found that medication administration errors occurred in almost 20% of doses administered.2 Data from U.S. Pharmacopeia’s (USP’s) medication error reporting database, MEDMARX®, indicates that an error at the point of administration is least likely to be intercepted before reaching the patient, compared to other phases of the medication-use process.3&lt;/p&gt;    &lt;p&gt;One form of technology that may address administration errors is a bar-code medication administration (BCMA) system. BCMA c...&lt;/p&gt; &lt;/div&gt;  &lt;p&gt;&lt;/p&gt; [&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics"&gt;Pharmacoinformatics Feed From Poikonen's Evernote&lt;/a&gt;]     &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-5009596431445039802?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/5009596431445039802/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/medication-errors-occurring-with-use-of.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5009596431445039802'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5009596431445039802'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/medication-errors-occurring-with-use-of.html' title='Medication Errors Occurring with the Use of Bar-Code Administration Technology'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-3393126767113505788</id><published>2009-02-01T06:29:00.001-08:00</published><updated>2009-02-01T06:29:44.099-08:00</updated><title type='text'>Study: Health IT Use Can Lower Hospital Mortality Rates, Costs</title><content type='html'>&lt;p&gt;Landmark study in Archives of Internal Medicine with nice editorial by David Bates.&amp;#160;&amp;#160; I have some thoughts on what the pharmacy department might be doing in these hospitals where there was a difference in mortality; will post later.&amp;#160; Would like to see similar study on outcomes with and without BCMA (Hey – a guy can dream).&lt;/p&gt;  &lt;p&gt;&lt;!--break--&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics#904913ea-210c-4169-84b1-79154abb5ba4"&gt;Study: Health IT Use Can Lower Hospital Mortality Rates, Costs - iHealthBeat&lt;/a&gt; - &lt;em&gt;&lt;/em&gt;&lt;/p&gt;  &lt;div class="ennote"&gt;Study: Health IT Use Can Lower Hospital Mortality Rates, Costs    &lt;p&gt;Hospitals' use of health IT is associated with lower mortality rates, complications and costs, according to a &lt;a href="http://archinte.ama-assn.org/cgi/content/full/169/2/108" target="_blank" shape="rect"&gt;new study&lt;/a&gt; published in the Archives of Internal Medicine, &lt;a href="http://www.washingtonpost.com/wp-dyn/content/article/2009/01/26/AR2009012601987.html" target="_blank" shape="rect"&gt;Reuters/Washington Post&lt;/a&gt; reports (Steenhuysen, Reuters/Washington Post, 1/26).&lt;/p&gt;    &lt;p&gt;Study Details&lt;/p&gt;    &lt;p&gt;The researchers divided clinical IT systems into four categories:&lt;/p&gt;    &lt;ul&gt;     &lt;li&gt;Clinical decision support; &lt;/li&gt;      &lt;li&gt;Medical notes and records; &lt;/li&gt;      &lt;li&gt;Order Entry; and &lt;/li&gt;      &lt;li&gt;Test Results. &lt;/li&gt;   &lt;/ul&gt;    &lt;p&gt;The researchers surveyed physicians at 41 urban hospitals in Texas about their use of IT systems in each of the four categories. The researchers then looked at the relationship between IT usage and the rates of inpatient death, complications, costs and lengths of stay for 167,233 patients ages 50 and older who were admitted to the participating hospitals in 2005 and 2006.&lt;/p&gt;    &lt;p&gt;The study was funded by the Commonwealth Fund (Conn, &lt;a href="http://www.modernhealthcare.com/article/20090126/REG/301269942/-1/TODAYSNEWS" target="_blank" shape="rect"&gt;Modern Healthcare&lt;/a&gt;, 1/26).&lt;/p&gt;    &lt;p&gt;Study Findings&lt;/p&gt;    &lt;p&gt;The study found that patients at hospitals that ranked highest in health IT use by physicians were 16% less likely to develop complications than patients treated at hospitals where physicians used IT less.&lt;/p&gt;    &lt;p&gt;The study also found that patient mortality rates were 15% lower at hospitals that ranked highest in the use of software to automate patient records and notes.&lt;/p&gt;    &lt;p&gt;In addition, heart attack patients had a 9% lower risk of dying and bypass patients had a 55% lower risk of dying at hospitals with high scores in use of software to track physicians' orders, according to the study.&lt;/p&gt;    &lt;p&gt;&amp;quot;If these results were to hold for all hospitals in the United States, computerizing notes and records might have the potential to save 100,000 lives annually,&amp;quot; Neil Poe of Johns Hopkins University School of Medicine, who worked on the study, said (Reuters/Washington Post, 1/26).&lt;/p&gt; &lt;/div&gt;  &lt;p&gt;&lt;/p&gt; [&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics"&gt;Pharmacoinformatics Feed From Poikonen's Evernote&lt;/a&gt;]     &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-3393126767113505788?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/3393126767113505788/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/study-health-it-use-can-lower-hospital.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3393126767113505788'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3393126767113505788'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/02/study-health-it-use-can-lower-hospital.html' title='Study: Health IT Use Can Lower Hospital Mortality Rates, Costs'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-3613640314351275256</id><published>2009-01-28T06:39:00.000-08:00</published><updated>2009-02-01T06:39:56.291-08:00</updated><title type='text'>(AHRQ) Medical Errors &amp; Patient Safety Update</title><content type='html'>&lt;p&gt;Great idea to standardize evidence of interventions &lt;/p&gt;  &lt;p&gt;&lt;!--break--&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics#07b38365-3372-4088-bb81-88db7c99106a"&gt;(AHRQ) Medical Errors &amp;amp; Patient Safety Update&lt;/a&gt; - &lt;/p&gt;  &lt;div class="ennote"&gt;&lt;a href="http://healthnewnews.blogspot.com/2009/01/agency-for-healthcare-research-and_29.html" target="_blank" shape="rect"&gt;&lt;em&gt;Agency for Healthcare Research and Quality (AHRQ) Medical Errors &amp;amp; Patient Safety Update&lt;/em&gt;&lt;/a&gt;&lt;em&gt; &lt;/em&gt;    &lt;div&gt;&lt;/div&gt;    &lt;div&gt;     &lt;p&gt;&lt;/p&gt;      &lt;p&gt;&lt;/p&gt;      &lt;p&gt;&lt;/p&gt;     &lt;b&gt;&lt;/b&gt;      &lt;p&gt;AHRQ Awards Contract to Develop Criteria to Assess the Evidence Base for Patient Safety Practices On January 8, AHRQ awarded a contract to develop a set of criteria to be used for assessing the evidence base for the effectiveness and safety of patient safety practices (PSPs) in future evidence reviews and for use by implementers of PSPs. The $1 million contract, Assessing the Evidence for Context-Sensitive Effectiveness and Safety of Patient Safety Practices: Developing Criteria was awarded to RAND, Johns Hopkins University, and the University of California-San Francisco, working in partnership with the Karolinska Institute (Sweden) and a technical expert panel. AHRQ recognizes that there is a need for a suitable set of criteria by which to assess which patient safety practices will work and are safe in specific settings. All across the country, providers, hospitals, health systems and policymakers are attempting to improve the safety of patient care, and are looking for guidance on what works. This 1-year initiative will be the first to take into account the complexity of patent safety interventions in the real world and tie those components to research and evaluation considerations. Those considerations include assessment of theoretical models for designing PSPs and the usefulness of innovative methods for evaluating intervention results. For more information, please contact the AHRQ Project Officer, Denise Dougherty, at &lt;a href="mailto:Denise.Dougherty@ahrq.hhs.gov" target="_blank" shape="rect"&gt;Denise.Dougherty@ahrq.hhs.gov&lt;/a&gt; or 301.427-1868. &lt;/p&gt;   &lt;/div&gt; &lt;/div&gt; &lt;strong&gt;[&lt;/strong&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics"&gt;&lt;strong&gt;Pharmacoinformatics Feed From Poikonen's Evernote&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;]&lt;/strong&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-3613640314351275256?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/3613640314351275256/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/ahrq-medical-errors-patient-safety.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3613640314351275256'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3613640314351275256'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/ahrq-medical-errors-patient-safety.html' title='(AHRQ) Medical Errors &amp;amp; Patient Safety Update'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4830153404977131583</id><published>2009-01-28T06:35:00.000-08:00</published><updated>2009-02-01T06:37:53.165-08:00</updated><title type='text'>Drug Induced QT Prolongation</title><content type='html'>&lt;p&gt;Here is a series of articles on medication QT Prolongation. My sense is it is a under recognized problem, although I have no basis for this view, just a feeling.&amp;#160; This would make for an interesting CDSS to incorporate wave form analysis.&amp;#160; &lt;/p&gt;  &lt;p&gt;&lt;!--break--&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics#924d4030-8cbe-47a1-a594-c2dbb836d8aa"&gt;Drug Induced QT Prolongation&lt;/a&gt; - &lt;em&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics#924d4030-8cbe-47a1-a594-c2dbb836d8aa"&gt;&lt;img src="http://www.evernote.com/shard/s2/thumb/924d4030-8cbe-47a1-a594-c2dbb836d8aa" align="right" /&gt;&lt;/a&gt; &lt;/em&gt;&lt;/p&gt;  &lt;div class="ennote"&gt;   &lt;div&gt;     &lt;div&gt;       &lt;div&gt;Editors' view&lt;/div&gt;        &lt;div&gt;Drug-induced long QT syndrome and drug development&lt;/div&gt;     &lt;/div&gt;      &lt;div&gt;J. M. Ritter,        &lt;div&gt;Department of Clinical Pharmacology, School of Medicine at Guy's, King's College &amp;amp; St Thomas' Hospitals, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH UK&lt;/div&gt;     &lt;/div&gt;      &lt;div&gt;&lt;/div&gt;      &lt;div&gt;Copyright Journal compilation © 2008 Blackwell Publishing Ltd&lt;/div&gt;   &lt;/div&gt;    &lt;div&gt;     &lt;div&gt;       &lt;div&gt;ABSTRACT&lt;/div&gt;       &lt;a href="#ss1" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss2" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss3" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss4" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss8" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss9" shape="rect"&gt;&lt;/a&gt;        &lt;div&gt;No Abstract&lt;/div&gt;     &lt;/div&gt;   &lt;/div&gt;    &lt;div&gt;&lt;/div&gt;    &lt;div&gt;     &lt;div&gt;DIGITAL OBJECT IDENTIFIER (DOI)&lt;/div&gt; 10.1111/j.1365-2125.2008.03275.x &lt;a href="http://www3.interscience.wiley.com/doiinfo.html" target="_new" shape="rect"&gt;About DOI&lt;/a&gt;&lt;/div&gt;    &lt;div&gt;&lt;a shape="rect" name="s1-1"&gt;&amp;#160;&lt;/a&gt;       &lt;div&gt;&lt;a shape="rect" name="ss1"&gt;&amp;#160;&lt;/a&gt;         &lt;div&gt;&lt;a shape="rect" name="h1"&gt;&amp;#160;&lt;/a&gt; Introduction&lt;a href="#abstract" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss1" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss2" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss3" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss4" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss8" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss9" shape="rect"&gt;&lt;/a&gt;           &lt;p&gt;September's issue is themed around cardiovascular clinical pharmacology. It includes articles on a range of topics, spanning a review of the role of the renin-angiotensin system in atrial fibrillation &lt;a href="#b1" shape="rect"&gt;[1]&lt;/a&gt;, through the effect of atorvastatin on high-sensitivity CRP in acute coronary syndrome &lt;a href="#b2" shape="rect"&gt;[2]&lt;/a&gt;, and the pharmacokinetics and pharmacodynamics of nicorandil in healthy and acute heart failure subjects &lt;a href="#b3" shape="rect"&gt;[3]&lt;/a&gt; to the influence of paraoxonase-1 (PON-1) phenotype on the response of paraoxonase activity to statins &lt;a href="#b4" shape="rect"&gt;[4]&lt;/a&gt;. Several papers &lt;a href="#b5" shape="rect"&gt;[5–7]&lt;/a&gt; relate directly or indirectly to effects of drugs on the electrocardiographic QT interval, and it is on this subject that this Editors' View is focused.&lt;/p&gt;       &lt;/div&gt;       &lt;a shape="rect" name="ss2"&gt;&amp;#160;&lt;/a&gt;         &lt;div&gt;&lt;a shape="rect" name="h2"&gt;&amp;#160;&lt;/a&gt; The vulnerable period and the long QT syndrome&lt;a href="#abstract" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss1" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss2" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss3" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss4" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss8" shape="rect"&gt;&lt;/a&gt;&lt;a href="#ss9" shape="rect"&gt;&lt;/a&gt;           &lt;p&gt;George Ralph Mines identified the 'vulnerable period' within the cycle of the cardiac action potential/pacemaker (or resting) potential &lt;a href="#b8" shape="rect"&gt;[8]&lt;/a&gt;. (Mines &lt;a href="#b9" shape="rect"&gt;[9]&lt;/a&gt;, a contemporary at Cambridge of AV Hill, also described cardiac re-entry and identified the active principle of munchi arrow poison as strophanthin. He was appointed professor of physiology at McGill University in Canada aged 28, but died tragically soon thereafter – of which more later).&lt;/p&gt;          &lt;p&gt;A ventricular extra beat falling early in the cardiac cycle, so that it coincides with ventricular repolarisation (the 'R on T' phenomenon), can provoke ventricular tachycardia (VT), and/or ventricular fibrillation (VF). The QT interval is measured from the beginning of the QRS complex (whether Q or R wave) to the end of the T wave. The latter may be difficult to define, especially when a U wave succeeds the T; however, the U wave tends to b...&lt;/p&gt;       &lt;/div&gt;     &lt;/div&gt;   &lt;/div&gt; &lt;/div&gt;  &lt;p&gt;&lt;/p&gt; [&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics"&gt;Pharmacoinformatics Feed From Poikonen's Evernote&lt;/a&gt;]     &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4830153404977131583?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4830153404977131583/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/drug-induced-qt-prolongation.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4830153404977131583'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4830153404977131583'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/drug-induced-qt-prolongation.html' title='Drug Induced QT Prolongation'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2724988329580853563</id><published>2009-01-26T04:05:00.000-08:00</published><updated>2009-01-26T04:40:36.162-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Uncategorized'/><category scheme='http://www.blogger.com/atom/ns#' term='RxNorm'/><title type='text'>RxNorm and CMS in eRx 2009 Call Letter</title><content type='html'>It seem clear from this CMS correspondence that RxNorm will be replacing NDC codes (finally). It is time to contact your pharmacy system vendor to insure that they put the RxNorm code in their data structure. All of the major drug database vendors support the RxNorm CUI codes. &lt;!--break--&gt;&lt;br /&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics#7eb394fc-d3fb-48f6-875b-c8bbcc7300da"&gt;RxNorm and CMS in eRx 2009&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics#7eb394fc-d3fb-48f6-875b-c8bbcc7300da"&gt;Call Letter&lt;/a&gt; -&lt;br /&gt;&lt;br /&gt;&lt;div class="ennote"&gt;&lt;br /&gt;  &lt;em&gt;&lt;i&gt;&lt;b&gt;H. RxNorm&lt;/b&gt;&lt;/i&gt; &lt;b&gt;CMS will continue to utilize a Formulary Reference File (FRF) and proxy National Drug Codes (NDCs) for HPMS submission of Part D formularies. For CY2009, CMS also will introduce the RxNorm&lt;/b&gt; nomenclature for the FRF drugs because we are exploring &lt;b&gt;RxNorm&lt;/b&gt; as a potential alternative to proxy NDCs for formulary submissions in future years. &lt;b&gt;RxNorm&lt;/b&gt; is a standardized nomenclature for clinical drugs produced by the National Library of Medicine (http://www.nlm.nih.gov/research/umls/&lt;b&gt;rxnorm&lt;/b&gt;/index.html). CMS is working with the &lt;a name="60"&gt;&lt;b&gt;Page 60&lt;/b&gt;&lt;/a&gt; 60 National Library of Medicine to evaluate whether &lt;b&gt;RxNorm&lt;/b&gt; would provide a more effective means of drug product identification for the FRF. CMS recognizes the value of a standardized nomenclature system for the purpose of Part D formulary submission and review and for its potential application as electronic prescribing evolves. For each CY2009 FRF proxy code, the &lt;b&gt;RxNorm&lt;/b&gt; semantic names and &lt;b&gt;RxNorm&lt;/b&gt; concept unique identifier (RXCUI) code (when available) will be included. Part D sponsors should be aware that FRF format changes will be forthcoming. CMS wishes to clarify again that the submission process for CY 2009 formularies will not involve the use of &lt;b&gt;RxNorm&lt;/b&gt; concept unique identifiers. We will continue to investigate the benefits of using these codes for subsequent plan years. Should CMS determine that the utilization of &lt;b&gt;RxNorm&lt;/b&gt; would be a beneficial means for indicating drug coverage during the formulary submission and review process for CY 2010, we will notify plans in the fall of 2008 of such changes.&lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&lt;b&gt;[&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics"&gt;Pharmacoinformatics Feed From Poikonen's Evernote&lt;/a&gt;]&lt;/b&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2724988329580853563?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2724988329580853563/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/rxnorm-and-cms-in-erx-2009-call-letter.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2724988329580853563'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2724988329580853563'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/rxnorm-and-cms-in-erx-2009-call-letter.html' title='RxNorm and CMS in eRx 2009 Call Letter'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6558103421630022945</id><published>2009-01-21T13:11:00.001-08:00</published><updated>2009-01-21T13:11:42.977-08:00</updated><title type='text'>Rock and Roll Health IT Funding</title><content type='html'>&lt;p&gt;&lt;/p&gt;  &lt;p&gt;The source of this report is interesting.&amp;#160; Time to turn up the amps to “11”&lt;/p&gt;  &lt;h4&gt;Economist's Letter to Obama Calls for Health Care IT Investment&lt;/h4&gt;  &lt;p&gt;In an &lt;a href="http://www.rollingstone.com/politics/story/25456948/what_obama_must_do"&gt;open letter&lt;/a&gt; to President Obama published in the February issue of &lt;i&gt;&lt;strong&gt;Rolling Stone&lt;/strong&gt;&lt;/i&gt;, Nobel Prize-winning economist Paul Krugman calls for spending federal money &amp;quot;on things of lasting value,&amp;quot; such as health IT, &lt;i&gt;&lt;a href="http://www.healthcareitnews.com/news/economist-calls-healthcare-it-part-reform"&gt;Healthcare IT News&lt;/a&gt;&lt;/i&gt; reports.&lt;/p&gt;  &lt;p&gt;Krugman -- a professor of economics and international affairs at Princeton University and columnist for the &lt;i&gt;New York Times&lt;/i&gt; -- writes that health care IT, &amp;quot;like similar infrastructure investments, would help create jobs,&amp;quot; which then would address the economic crisis. &lt;/p&gt;  &lt;p&gt;Krugman writes that Obama should &amp;quot;improve information technology in the health care sector, a crucial part of any health care reform.&amp;quot;&lt;/p&gt;  &lt;p&gt;Obama has said he wants to spend $50 billion over five years to support the adoption and use of health care IT (Monegain, &lt;i&gt;Healthcare IT News&lt;/i&gt;, 1/19).&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6558103421630022945?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6558103421630022945/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/rock-and-roll-health-it-funding.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6558103421630022945'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6558103421630022945'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/rock-and-roll-health-it-funding.html' title='Rock and Roll Health IT Funding'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-1821643684792507706</id><published>2009-01-21T12:52:00.001-08:00</published><updated>2009-01-21T12:52:38.881-08:00</updated><title type='text'>More Opinion and still lack of science on BCMA</title><content type='html'>&lt;p&gt;This is getting downright weird.&amp;#160; I am starting to feel like Henry Fonda in 12 Angry Men, calling for real proof of decrease med errors rather than jumping on the BCMA bandwagon.&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;&lt;b&gt;New Report on Lessons from AHRQ-Funded Barcode Medication Administration Projects&lt;/b&gt;&lt;/strong&gt;&lt;/p&gt;  &lt;p&gt;The &lt;a href="http://healthit.ahrq.gov/"&gt;AHRQ National Resource Center for Health Information Technology&lt;/a&gt; has released a new report that summarizes key findings from grantees who have examined how applications such as barcode medication administration can improve the quality, safety, efficiency, and effectiveness of health care. The report focuses on lessons learned, challenges, and opportunities associated with introducing these applications into real-world clinical settings so that others who wish to implement and use barcode medication administration and electronic medication administration record technologies can learn from the experiences of these AHRQ projects. Select to access the &lt;a href="http://healthit.ahrq.gov/images/dec08bcmareport/bcma_issue_paper.htm"&gt;report&lt;/a&gt;.&lt;/p&gt;  &lt;p&gt;------------------------------------------------------------------------------------------&lt;/p&gt;  &lt;p&gt;Would like to hear reactions to the just released report.&lt;/p&gt;  &lt;p&gt;My spin: It is my view that the statement below from the report does &lt;b&gt;NOT&lt;/b&gt; support BCMA.&lt;/p&gt;  &lt;p&gt;“Research has demonstrated successful reductions in the rate of medication administration and dispensing errors after the implementation of barcoding systems,8-16”&lt;/p&gt;  &lt;p&gt;Reference 8 and 9 are on the dispensing process that are elegant and very convincing for the dispensing process not BCMA.&lt;/p&gt;  &lt;p&gt;Reference 10-16 are not research studies showing reduction in errors but opinion pieces. They assume that BCMA will decrease errors and give commentary from that perspective. None of the references are research to show decrease medication errors. Something as important as this needs science not opinion.&lt;/p&gt;  &lt;p&gt;8. Poon EG, Cina JL Churchill W, Patel N, et al. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy. Ann Intern Med 2006 Sep 19;145(6):426-34. &lt;/p&gt;  &lt;p&gt;9. Poon EG, Cina JL, Churchill WW, et al. Effect of bar-code technology on the incidence of medication dispensing errors and potential adverse drug events in a hospital pharmacy. AMIA Annu Symp Proc 2005:1085. &lt;/p&gt;  &lt;p&gt;10. Patterson ES, Rogers ML, Render ML. Fifteen best practice recommendations for bar-code medication administration in the veterans health administration. Jt Comm J Qual Saf 2004 Jul;30(7):355-65. &lt;/p&gt;  &lt;p&gt;11. Wright AA, Katz IT. Bar coding for patient safety. N Engl J Med 2005;353:329-31. &lt;/p&gt;  &lt;p&gt;12. Patchett JA. Bar coding: A practical approach to improving medication safety. ASHP Advantage; North Shore LIJ; Hospira; 2004:1-11. &lt;/p&gt;  &lt;p&gt;13. Department of Health and Human Services: Food and Drug Administration. Bar code label requirements for human drug products and biological products; final rule. Federal Register 2004;69(38):201-601. &lt;/p&gt;  &lt;p&gt;14. Department of Health and Human Services: Food and Drug Administration. Bar code label requirements for human drug products and biological products; final rule. Federal Register 2004;69(38):201-601. &lt;/p&gt;  &lt;p&gt;15. The Joint Commission. http://www.jointcommission.org/. Accessed August 30, 2008.&lt;/p&gt;  &lt;p&gt;16. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press; 1999.&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-1821643684792507706?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/1821643684792507706/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/more-opinion-and-still-lack-of-science.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1821643684792507706'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1821643684792507706'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/more-opinion-and-still-lack-of-science.html' title='More Opinion and still lack of science on BCMA'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2683698549413766525</id><published>2009-01-20T13:42:00.001-08:00</published><updated>2009-01-20T13:42:10.961-08:00</updated><title type='text'>If BCMA was a drug</title><content type='html'>&lt;p&gt;So would you take a drug that had zero studies on its safety and efficacy?&amp;#160; Would labeling claims such as “over 24 million doses administered with zero serious side effects” have the wrath of the FDA down on them.&lt;/p&gt;  &lt;p&gt;In light Coca-Cola being served with a &lt;a href="http://www.mediapost.com/publications/?fa=Articles.san&amp;amp;s=98473&amp;amp;Nid=51273&amp;amp;p=988455" target="_blank"&gt;class-action lawsuit&lt;/a&gt;, charging the Atlanta beverage giant with deceptive and unsubstantiated claims on its Vitaminwater beverages, consider Intellidot’s claim in a recent advertising.&lt;/p&gt;  &lt;blockquote&gt;   &lt;p&gt;“Our barcode point-of-care system has allowed our clients to deliver over 24 million medication administrations with zero serious five rights med errors.”&lt;/p&gt; &lt;/blockquote&gt;  &lt;p&gt;Intellidot is asking for and just might get into some deep do do over unsubstantiated statements such as this.&amp;#160; The studies to which they refer are internal, not peer reviewed and of a relative small sample size as admitted by the company in a ASHP list serv post.&amp;#160; Desperate times call for desperate marketing is my guess.&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2683698549413766525?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2683698549413766525/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/if-bcma-was-drug.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2683698549413766525'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2683698549413766525'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/if-bcma-was-drug.html' title='If BCMA was a drug'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-3894745730735409681</id><published>2009-01-18T17:49:00.001-08:00</published><updated>2009-01-18T17:49:03.902-08:00</updated><title type='text'>Nursing Informatics Conferences in 2009</title><content type='html'>&lt;p&gt;Am Nursing Informatics Assoc. speaker proposals due January 25, for Las Vegas conference April 23-25, 2009.&amp;#160; They do not pay for anything but a registration, fyi.&lt;/p&gt;  &lt;p&gt;&lt;a title="http://www.ania.org/Speaker&amp;amp;Poster%2009.htm" href="http://www.ania.org/Speaker&amp;amp;Poster%2009.htm"&gt;http://www.ania.org/Speaker&amp;amp;Poster%2009.htm&lt;/a&gt;&lt;/p&gt;  &lt;p&gt;Also found this &lt;a title="http://www.ni2009.org/" href="http://www.ni2009.org/"&gt;http://www.ni2009.org/&lt;/a&gt;&amp;#160;&lt;strong&gt;The 10th International Congress on Nursing Informatics welcomes you to Helsinki Finland on 28 June – 1 July 2009.&lt;/strong&gt;&amp;#160;&amp;#160; Paper submission date has passed (bummer).&lt;/p&gt;  &lt;p&gt;Helsinki is a wonderful place to visit, both as a historic, majestic city and summer solstice in Finland is quite a celebration.&amp;#160; Let’s have the 1st International Pharmacy Informatics Congress there in 2010.&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-3894745730735409681?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/3894745730735409681/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/nursing-informatics-conferences-in-2009.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3894745730735409681'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3894745730735409681'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/nursing-informatics-conferences-in-2009.html' title='Nursing Informatics Conferences in 2009'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-287973300724236745</id><published>2009-01-18T08:34:00.000-08:00</published><updated>2009-01-18T08:44:59.249-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Uncategorized'/><title type='text'>Pharmacology in Second Life</title><content type='html'>&lt;p&gt;Pass this on to your pharmacology profs (and watch them weep)&lt;br /&gt;&lt;br /&gt;&lt;a href="http://scienceroll.com/2009/01/15/pharmatopia-pharmacology-in-second-life/"&gt;Pharmacology in Second Life&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;http://scienceroll.com/2009/01/15/pharmatopia-pharmacology-in-second-life/&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;I may have mentioned this before: This &lt;a href="http://scienceroll.com/about/"&gt;Medical Students blog&lt;/a&gt; is fantastic. Following him on &lt;a href="http://twitter.com/Berci"&gt;Twitter&lt;/a&gt; is fascinating.&lt;/p&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-287973300724236745?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/287973300724236745/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/pharmacology-in-second-life.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/287973300724236745'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/287973300724236745'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/pharmacology-in-second-life.html' title='Pharmacology in Second Life'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6464204135366513948</id><published>2009-01-13T13:44:00.000-08:00</published><updated>2009-01-20T13:44:35.397-08:00</updated><title type='text'>Pharmacoinformatics or Pharmacy Informatics Working Group</title><content type='html'>&lt;p&gt;It has been kicked around in the AMIA working group that perhaps we should change the name of the working group. Currently it is the Pharmacoinformatics Working Group. Here are some some items for your thought and considerations. First is our mission statement:&lt;/p&gt;  &lt;p&gt;Mission&lt;/p&gt;  &lt;p&gt;To promote interaction among AMIA members who are interested in the intersection of technology and medication management. This includes all aspects of the process from prescribing, dispensing, administration, monitoring, and educating about medication use within health care delivery systems.&lt;/p&gt;  &lt;ul&gt;   &lt;li&gt;Prescribing – clinical decision support to facilitate rational prescribing &lt;/li&gt;    &lt;li&gt;Verifying/Dispensing – interpretation, translation and perfection of medication orders, including informatics and technology in dispensing &lt;/li&gt;    &lt;li&gt;Administration – the information flow and decision support with electronic medication administration, 5 right checking and documentation &lt;/li&gt;    &lt;li&gt;Monitoring – relating to the use of ADE surveillance/prevention, pharmaco-epidemiology, pharmaco-vigilance and pharmacoeconomics to enhance patient outcomes &lt;/li&gt;    &lt;li&gt;Education – promoting professional and patient education &lt;/li&gt; &lt;/ul&gt;  &lt;p&gt;Here are some graphical representations. First is informatics defined by Ted Shortliffe.&lt;/p&gt;  &lt;p&gt;&lt;img height="360" alt="Slide1.jpg" src="http://pharmacyinformatics.files.wordpress.com/2009/01/slide1.jpg" width="480" /&gt;&lt;/p&gt;  &lt;p&gt;This is an adaptation for pharmacy&lt;/p&gt;  &lt;p&gt;&lt;img height="360" alt="Slide3.jpg" src="http://pharmacyinformatics.files.wordpress.com/2009/01/slide3.jpg" width="480" /&gt;&lt;/p&gt;  &lt;p&gt;Note that Pharmacy informatics does touch patients, society and then moves to professional pharmacy practice.&lt;/p&gt;  &lt;p&gt;The next few diagrams are adaption from Terry Seaton's work. We discussed the exact location of each circle and could not exactly get it right. Both are submitted for your view.&lt;/p&gt;  &lt;p&gt;&lt;img height="360" alt="Slide1.jpg" src="http://pharmacyinformatics.files.wordpress.com/2009/01/slide11.jpg" width="480" /&gt;&lt;/p&gt;  &lt;p&gt;and this one, that is a little bit different.&lt;/p&gt;  &lt;p&gt;&lt;img height="360" alt="Slide4.jpg" src="http://pharmacyinformatics.files.wordpress.com/2009/01/slide4.jpg" width="480" /&gt;&lt;/p&gt;  &lt;p&gt;So the question remains. Pharmacoinformatics or Pharmacy Informatics.&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6464204135366513948?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6464204135366513948/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/pharmacoinformatics-or-pharmacy.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6464204135366513948'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6464204135366513948'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/pharmacoinformatics-or-pharmacy.html' title='Pharmacoinformatics or Pharmacy Informatics Working Group'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-1929033281631448840</id><published>2009-01-07T03:06:00.000-08:00</published><updated>2009-01-07T03:14:39.924-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Uncategorized'/><title type='text'>The Best Medical Blogs for 2008</title><content type='html'>&lt;p&gt;The polls are open to vote on the &lt;a href="http://www.medgadget.com/archives/2009/01/the_2008_medical_weblog_awards_the_polls_are_open.html"&gt;best Medical Blogs&lt;/a&gt;.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;http://www.medgadget.com/archives/2009/01/the_2008_medical_weblog_awards_the_polls_are_open.html&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-1929033281631448840?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/1929033281631448840/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/best-medical-blogs-for-2008.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1929033281631448840'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1929033281631448840'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/best-medical-blogs-for-2008.html' title='The Best Medical Blogs for 2008'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6852248904695329683</id><published>2009-01-06T16:59:00.000-08:00</published><updated>2009-01-06T16:59:00.233-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='2.0'/><category scheme='http://www.blogger.com/atom/ns#' term='Uncategorized'/><category scheme='http://www.blogger.com/atom/ns#' term='web'/><title type='text'>Twitter List</title><content type='html'>&lt;p&gt;http://www.medicalstudentblog.co.uk/twitter-doctors-medical-students-and-medicine-related/&lt;/p&gt;&lt;br /&gt;&lt;p&gt;If you are on Twitter, lets get the pharmacist list longer1&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6852248904695329683?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6852248904695329683/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/twitter-list.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6852248904695329683'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6852248904695329683'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2009/01/twitter-list.html' title='Twitter List'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-8553697670352331989</id><published>2008-12-31T06:12:00.001-08:00</published><updated>2008-12-31T06:12:39.657-08:00</updated><title type='text'>BMJ YouTube Channel</title><content type='html'>&lt;p&gt;British Medical Journal has a &lt;a href="http://uk.youtube.com/bmjmedia" target="_blank"&gt;Youtube channel&lt;/a&gt; that is very interesting. (via the &lt;a href="http://scienceroll.com/" target="_blank"&gt;ScienceRoll Blog&lt;/a&gt;)&lt;/p&gt;  &lt;p&gt;In a search I did not see anything on pharmacy or therapeutics.&amp;#160; Anyone?&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-8553697670352331989?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/8553697670352331989/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/bmj-youtube-channel.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/8553697670352331989'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/8553697670352331989'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/bmj-youtube-channel.html' title='BMJ YouTube Channel'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-5025554288751390135</id><published>2008-12-30T14:41:00.001-08:00</published><updated>2008-12-30T14:41:40.200-08:00</updated><title type='text'>Clinical Pharmacy Services Save $4.81 on the Dollar</title><content type='html'>&lt;p&gt;This is from a recent ASHP newsletter.&amp;#160; I find this to be freaking awesome.&amp;#160; Hope to comment on the ones that have informatic implications for even better improvements and ROI.&lt;/p&gt;  &lt;p&gt;An &lt;a href="http://www.pharmacotherapy.org/pdf/free/Pharm2811_Perez-EconEval.pdf" target="_blank"&gt;evaluation of studies published from 2001 through 2005&lt;/a&gt; found a median savings of $4.81 for every dollar spent on clinical pharmacy services. The savings ranged from $1 to $34.60 per dollar spent.     &lt;br /&gt;&lt;a href="http://www.pharmacotherapy.org/pdf/free/Pharm2811_Perez-EconEval.pdf"&gt;http://www.pharmacotherapy.org/pdf/free/Pharm2811_Perez-EconEval.pdf&lt;/a&gt;&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-5025554288751390135?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/5025554288751390135/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/clinical-pharmacy-services-save-481-on.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5025554288751390135'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5025554288751390135'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/clinical-pharmacy-services-save-481-on.html' title='Clinical Pharmacy Services Save $4.81 on the Dollar'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-7763529878983432290</id><published>2008-12-29T16:34:00.000-08:00</published><updated>2008-12-29T16:43:24.608-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Uncategorized'/><category scheme='http://www.blogger.com/atom/ns#' term='bcma'/><category scheme='http://www.blogger.com/atom/ns#' term='CPOE'/><title type='text'>Top articles of 2008</title><content type='html'>&lt;p style="margin-bottom:0;font-weight:normal;"&gt;The envelope please..... Based on a completely unscientific, unsubstantiated, nonbinding, and otherwise meaningless poll of a small number of geeks willing to vote on such things --- the winners of the Top Pharmacoinformatic articles of 2008 are (drum roll please):&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;Workarounds to Barcode Medication Administration Systems: Their Occurrences, Causes, and Threats to Patient Safety doi:10.1197/jamia.M2616&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;Effectiveness of a Barcode Medication Administration System in Reducing Preventable Adverse Drug Events in a Neonatal Intensive Care Unit: A Prospective Cohort Study doi:10.1016/j.jpeds.2008.08.025&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;Severity of medication administration errors detected by a bar-code medication administration system American Journal of Health-System Pharmacy, Vol. 65, Issue 17, 1661-1666&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;The (Slowly) Vanishing Prescription Pad NEJM Volume 359:115-117 July 10, 2008 Number 2&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;Saving Lives, Saving Money: The Imperative for Computerized Physician Order Entry in Massachusetts Hospitals: Released Feb. 14, 2008 &lt;a href="http://www.masstech.org/ehealth/cpoe/cpoe08release.html"&gt;http://www.masstech.org/ehealth/cpoe/cpoe08release.html&lt;/a&gt;&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;Opportunities for Enhancing the FDA Guidance on Pharmacovigilance JAMA. 2008;300(8):952-954 (doi:10.1001/jama.300.8.952)&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;Drug target identification using side-effect similarity. Science 11 July 2008 &lt;a href="http://www.sciencemag.org/cgi/content/abstract/321/5886/263"&gt;&lt;/a&gt;&lt;a href="http://www.sciencemag.org/cgi/content/abstract/321/5886/263"&gt;http://www.sciencemag.org/cgi/content/abstract/321/5886/263&lt;/a&gt;&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;UCSF Program Achieves over 56% Reduction in Medication Administration Error &lt;a href="http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_26/ai_n24959258/print?tag=artBody;col1"&gt;http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_26/ai_n24959258/print?tag=artBody;col1&lt;/a&gt;&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;Improving antibiotic prescribing for adults with community acquired pneumonia: Does a computerised decision support system achieve more than academic detailing alone? &lt;a href="http://www.biomedcentral.com/1472-6947/8/35"&gt;http://www.biomedcentral.com/1472-6947/8/35&lt;/a&gt;&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;Pharmacy Informatics Syllabi in Doctor of Pharmacy Programs in the US &lt;a href="http://www.ajpe.org/view.asp?art=aj720489&amp;amp;pdf=yes"&gt;http://www.ajpe.org/view.asp?art=aj720489&amp;amp;pdf=yes&lt;/a&gt;&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;p style="margin-bottom:0;font-weight:normal;"&gt;&lt;strong&gt;Comments, critiques, kudos, criticisms or cynicisms are welcome and encouraged!&lt;/strong&gt;&lt;br /&gt;&lt;/p&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-7763529878983432290?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/7763529878983432290/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/top-articles-of-2008.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/7763529878983432290'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/7763529878983432290'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/top-articles-of-2008.html' title='Top articles of 2008'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6361818012616602572</id><published>2008-12-27T18:10:00.000-08:00</published><updated>2008-12-27T18:15:02.184-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='2.0'/><category scheme='http://www.blogger.com/atom/ns#' term='Uncategorized'/><category scheme='http://www.blogger.com/atom/ns#' term='web'/><title type='text'>Best of Medicine 2.0 in 2008</title><content type='html'>&lt;p&gt;Wow have a few days off? Check these out.&lt;/p&gt;From The Scienceroll.com - a terrific blog, fyi. This post lists the best of Medicine 2.0&lt;br /&gt;&lt;p&gt;http://scienceroll.com/2008/12/22/web-20-in-medicine-services-of-2008/&lt;/p&gt;&lt;strong&gt;Dean Giustini&lt;/strong&gt; at &lt;em&gt;UBC Academic Search - Google Scholar Blog&lt;/em&gt; created an incredibly useful list of the &lt;a href="http://weblogs.elearning.ubc.ca/googlescholar/archives/049814.html" target="_blank"&gt;best web 2.0-based medical services of 2008&lt;/a&gt;.&lt;div class="snap_preview"&gt;I have a few databases of similar sites:&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;a title="Virtual Medical Sites in Second Life!" href="http://scienceroll.com/2007/06/17/top-10-virtual-medical-sites-in-second-life/"&gt;Top 10: Virtual Medical Sites in Second Life!&lt;/a&gt;&lt;br /&gt;&lt;/li&gt;&lt;li&gt;&lt;a title="How to track the information you need!" href="http://scienceroll.com/2007/09/04/7-tips-how-to-track-the-information-you-need/"&gt;7 Tips: How to track the information you need!&lt;/a&gt;&lt;br /&gt;   &lt;/li&gt;&lt;li&gt;&lt;a title="the future of medicine?" href="http://scienceroll.com/2007/03/27/medical-wikis-the-future-of-medicine/"&gt;Medical wikis: the future of medicine?&lt;/a&gt;&lt;br /&gt;   &lt;/li&gt;&lt;li&gt;&lt;a title="The List" href="http://scienceroll.com/2008/05/24/community-sites-for-scientists-and-physicians-the-list/"&gt;Community Sites for Scientists and Physicians: The List&lt;/a&gt;&lt;br /&gt;   &lt;/li&gt;&lt;li&gt;&lt;a class="row-title" title="Edit " href="http://scienceroll.com/medicine-20/post.php?action=edit&amp;amp;post=2804"&gt;What you have to know about Twitter&lt;/a&gt;&lt;br /&gt;   &lt;/li&gt;&lt;li&gt;&lt;a title="The List" href="http://scienceroll.com/2007/08/29/sites-of-medicalscientific-videos-the-list/"&gt;Sites of Medical/Scientific Videos: The List&lt;/a&gt;&lt;br /&gt;   &lt;/li&gt;&lt;li&gt;&lt;a title="The Future of Medicine?" href="http://scienceroll.com/2008/05/18/call-your-doctor-online-the-future-of-medicine/" target="_blank"&gt;Call Your Doctor Online: The Future of Medicine?&lt;/a&gt;&lt;br /&gt;&lt;/li&gt;&lt;/ul&gt;And hundreds of &lt;a href="http://scienceroll.com/medicine-20/" target="_blank"&gt;posts here&lt;/a&gt;.&lt;br /&gt;Follow &lt;a href="http://weblogs.elearning.ubc.ca/googlescholar/" target="_blank"&gt;Dean Giustini&lt;/a&gt; and &lt;a href="http://clinicalcases.blogspot.com/" target="_blank"&gt;Ves Dimov&lt;/a&gt; for more.&lt;br /&gt; &lt;p&gt;&lt;a title="med320.jpg" href="http://scienceroll.files.wordpress.com/2007/06/med320.jpg"&gt;&lt;img src="http://scienceroll.files.wordpress.com/2007/06/med320.jpg?w=136&amp;amp;h=186&amp;amp;h=186" alt="" height="186" width="136" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;strong&gt;Possibly related posts: (automatically generated)&lt;/strong&gt;&lt;br /&gt;&lt;a rel="related" href="http://www.scienceroll.com/2007/04/29/medicine-20-the-beginning-of-a-new-era?referer=sphere_related_content/"&gt;Medicine 2.0: the beginning of a new era&lt;/a&gt;&lt;br /&gt;&lt;a rel="related" href="http://annietv600.wordpress.com/2007/03/07/free-cme?referer=sphere_related_content/"&gt;Free internal medicine case-based education through the World Wide Web&lt;/a&gt;&lt;br /&gt;&lt;a rel="related" href="http://www.downloadsquad.com/2008/11/19/statbrain-com-traffic-estimates-for-those-with-no-brain?icid=sphere_wpcom_inline"&gt;Statbrain.com : traffic estimates for those with no brain&lt;/a&gt;&lt;br /&gt;&lt;a rel="related" href="http://online.wsj.com/article/SB122695947215634931.html?referer=sphere_related_content"&gt;Baidu Shares Fall As Much As 27%&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6361818012616602572?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6361818012616602572/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/best-of-medicine-20-in-2008.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6361818012616602572'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6361818012616602572'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/best-of-medicine-20-in-2008.html' title='Best of Medicine 2.0 in 2008'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4238199147680406470</id><published>2008-12-24T06:57:00.001-08:00</published><updated>2008-12-24T06:57:36.629-08:00</updated><title type='text'>DDI Software and Pharmacists</title><content type='html'>&lt;p&gt;This study in JAMA documents that 1 in 25 elderly Americans take a potentially harmful combination of medications.&amp;#160; Is this and indictment on the lousy job pharmacists are doing picking up on these combos and how bad the DDI checking software is?&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States&lt;/strong&gt;    &lt;br /&gt;&lt;em&gt;JAMA.&lt;/em&gt; 2008; 300:2867-2878.&amp;#160; &lt;a href="http://jama.ama-assn.org/cgi/content/abstract/300/24/2867?etoc"&gt;ABSTRACT&lt;/a&gt; | &lt;a href="http://jama.ama-assn.org/cgi/content/full/300/24/2867?etoc"&gt;FULL TEXT&lt;/a&gt; | &lt;a href="http://jama.ama-assn.org/cgi/reprint/300/24/2867?etoc"&gt;PDF&lt;/a&gt;&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4238199147680406470?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4238199147680406470/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/ddi-software-and-pharmacists.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4238199147680406470'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4238199147680406470'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/ddi-software-and-pharmacists.html' title='DDI Software and Pharmacists'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4927135313289370814</id><published>2008-12-18T14:27:00.000-08:00</published><updated>2008-12-18T14:29:14.372-08:00</updated><title type='text'>Chemoinformatics</title><content type='html'>&lt;div&gt;We spent some time defining pharmaco and pharmacy informatics.  Now Chemoinformatics!&lt;/div&gt;This is really interesting from &lt;a href="http://rbaltman.wordpress.com/2008/12/17/biology-chemistry-bioinformatics-chemoinformatics/"&gt;Russ Altman's Blog&lt;/a&gt;.&lt;div&gt;http://rbaltman.wordpress.com/2008/12/17/biology-chemistry-bioinformatics-chemoinformatics/&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4927135313289370814?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4927135313289370814/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/chemoinformatics.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4927135313289370814'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4927135313289370814'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/chemoinformatics.html' title='Chemoinformatics'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4222507318875313127</id><published>2008-12-16T06:27:00.001-08:00</published><updated>2008-12-16T06:29:31.910-08:00</updated><title type='text'>More BCMA Emotion, no science</title><content type='html'>&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;At the BCMA networking session at the ASHP meeting, the floor was opened up for questions.  So of course, I needed to ask “the ROI question” to the panel that was assembled.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;So here is my recollection of my question: Given the current financial situation and the fact that there are no good studies to show the value of BCMA, how do you justify the practice?&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;The responses where to the effect:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;ul&gt;   &lt;ul&gt;     &lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;There is no ROI.  We are doing everything to make the medication administration safe at our hospital, that is what we are all about&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt; &lt;/span&gt;&lt;/li&gt;   &lt;/ul&gt;    &lt;ul&gt;     &lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;I put up all of the headlines of the medication administration errors to the Board and then told them a couple of incidence of near misses, and they sucked it up.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt; &lt;/span&gt;&lt;/li&gt;   &lt;/ul&gt;    &lt;ul&gt;     &lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;My kids swim team has layers of redundancy in the time keeping; shouldn’t we have protection for medication administration?&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt; &lt;/span&gt;&lt;/li&gt;   &lt;/ul&gt;    &lt;ul&gt;     &lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Wouldn’t you want this if your child was in the hospital?&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt; &lt;/span&gt;&lt;/li&gt;   &lt;/ul&gt;    &lt;ul&gt;     &lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;We have the statistics on near misses that are very impressive.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt; &lt;/span&gt;&lt;/li&gt;   &lt;/ul&gt;    &lt;ul&gt;     &lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Nurses are convinced that it works and would never go back to the old way.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt; &lt;/span&gt;&lt;/li&gt;   &lt;/ul&gt; &lt;/ul&gt;  &lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;The near miss statistic was uncovered as bogus, in a later story of how nurses have all of the insulin stickers on the back of their badges and scan until they get a correct scan.  Where, presumably each scan is logged as a near miss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;I could not help think of what my old room mate taught me with example after example of selling cars.  People buy with emotion and justify with logic.  I clearly heard lots of emotion from the panel.  They where making emotional arguments and justifying the practice with logic, devoid of any science.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Excuse me, but isn’t pharmacy a scientific profession.  Shouldn’t we have a scientific explanation for BCMA as a practice.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;The science behind unit dose distribution was marvelous.  Yet, we continue to make emotional pleas for BCMA.  &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;This will not hold up over time, we need more science or we are toast.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4222507318875313127?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4222507318875313127/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/more-bcma-emotion-no-science.html#comment-form' title='2 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4222507318875313127'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4222507318875313127'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/more-bcma-emotion-no-science.html' title='More BCMA Emotion, no science'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>2</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4831640874333541750</id><published>2008-12-03T10:31:00.001-08:00</published><updated>2008-12-03T10:31:36.255-08:00</updated><title type='text'>Twitter for Health presentation</title><content type='html'>&lt;p&gt;Anyone on Twitter?&amp;#160; It is very cool.&amp;#160; Well, let me just say I am still attempting to find the ‘sweat spot’ for the use of this technology.&amp;#160; This PPT helps.&lt;/p&gt;  &lt;p&gt;My twitter name is “poikonen” if anyone dives in.&lt;/p&gt;  &lt;div id="__ss_418194" style="width: 425px; text-align: left"&gt;&lt;object style="margin:0px" height="355" width="425"&gt;&lt;param name="movie" value="http://static.slideshare.net/swf/ssplayer2.swf?doc=mla08twitter-1211311650671388-8" /&gt;&lt;param name="allowFullScreen" value="true" /&gt;&lt;param name="allowScriptAccess" value="always" /&gt;&lt;embed src="http://static.slideshare.net/swf/ssplayer2.swf?doc=mla08twitter-1211311650671388-8" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" width="425" height="355"&gt;&lt;/embed&gt;&lt;/object&gt;    &lt;div style="font-size: 11px; padding-top: 2px; font-family: tahoma,arial; height: 26px"&gt;&lt;a href="http://www.slideshare.net/?src=embed"&gt;&lt;img style="border-top-width: 0px; border-left-width: 0px; border-bottom-width: 0px; margin-bottom: -5px; border-right-width: 0px" alt="SlideShare" src="http://static.slideshare.net/swf/logo_embd.png" /&gt;&lt;/a&gt; | &lt;a title="View this slideshow on SlideShare" href="http://amiapiwg.blogspot.com/undefined"&gt;View&lt;/a&gt; | &lt;a href="http://www.slideshare.net/upload"&gt;Upload your own&lt;/a&gt;&lt;/div&gt; &lt;/div&gt;  &lt;p&gt;&lt;/p&gt;  &lt;p&gt;This is via the blog&amp;#160; &lt;a title="http://healthinformaticsblog.com/" href="http://healthinformaticsblog.com/"&gt;http://healthinformaticsblog.com/&lt;/a&gt;&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4831640874333541750?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4831640874333541750/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/twitter-for-health-presentation.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4831640874333541750'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4831640874333541750'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/12/twitter-for-health-presentation.html' title='Twitter for Health presentation'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2530022577929366821</id><published>2008-11-28T08:06:00.001-08:00</published><updated>2008-11-28T08:06:54.313-08:00</updated><title type='text'>Vote for the Top Ten Articles of 2008</title><content type='html'>Please vote for the top Pharmacoinformatic articles of the year &lt;a href="http://pharmacyinformatics.wordpress.com/"&gt;here&lt;/a&gt;. This completely subjective and unscientific poll of the Work group leadership will then be posted to the list servs.&lt;br /&gt;&lt;br /&gt;Thanks for your participation.&lt;br /&gt;-jp&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2530022577929366821?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2530022577929366821/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/vote-for-top-ten-articles-of-2008.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2530022577929366821'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2530022577929366821'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/vote-for-top-ten-articles-of-2008.html' title='Vote for the Top Ten Articles of 2008'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-3343944462447192836</id><published>2008-11-28T06:04:00.001-08:00</published><updated>2008-11-28T06:09:01.160-08:00</updated><title type='text'>Pharmacists Role in Health 2.0?</title><content type='html'>&lt;p&gt;Dr. David Kibbe's "Great American Health 2.0 Motorcycle Tour", is very interesting.  The senior health IT advisor for the &lt;a href="http://www.aafp.org/"&gt;American Academy of Family Physicians &lt;/a&gt;travels the country talking to people at &lt;a href="http://www.teladoc.com/"&gt;TelaDoc&lt;/a&gt;, &lt;a href="http://www.americanwell.com/"&gt;American Wel&lt;/a&gt;l, &lt;a href="http://www.patientslikeme.com/"&gt;PatientsLikeMe&lt;/a&gt;, &lt;a href="https://www.changehealthcare.com/"&gt;change:healthcare&lt;/a&gt;, &lt;a href="http://www.google.com/health"&gt;Google Health&lt;/a&gt;, &lt;a href="http://www.healthline.com/"&gt;Healthline&lt;/a&gt;, &lt;a href="http://www.medhelp.com/"&gt;MedHelp&lt;/a&gt;, &lt;a href="http://www.kosmix.com/"&gt;Kosmix&lt;/a&gt;, &lt;a href="http://well.blogs.nytimes.com/"&gt;New York Times columnist Tara Parker-Pope&lt;/a&gt;, &lt;a href="http://www.hellohealth.com/"&gt;Hello Health&lt;/a&gt; and a Tennessee &lt;a href="http://www.minuteclinic.com/"&gt;MinuteClinic&lt;/a&gt;.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;What I kept on thinking about is the role of the pharmacist in this context.  Not sure I have any insight, do you?&lt;/p&gt;&lt;embed src="http://services.brightcove.com/services/viewer/federated_f8/271552597" bgcolor="#FFFFFF" flashvars="videoId=1854859179&amp;amp;playerId=271552597&amp;amp;viewerSecureGatewayURL=https://console.brightcove.com/services/amfgateway&amp;amp;servicesURL=http://services.brightcove.com/services&amp;amp;cdnURL=http://admin.brightcove.com&amp;amp;domain=embed&amp;amp;autoStart=false&amp;amp;" base="http://admin.brightcove.com" name="flashObj" width="486" height="412" seamlesstabbing="false" type="application/x-shockwave-flash" swliveconnect="true" pluginspage="http://www.macromedia.com/shockwave/download/index.cgi?P1_Prod_Version=ShockwaveFlash"&gt;&lt;/embed&gt;&lt;br /&gt;&lt;p&gt;Thanks to Neil Versel's excellent &lt;a href="http://clinicalit.blogspot.com/"&gt;Healthcare IT Blog&lt;/a&gt; for posting this.&lt;/p&gt;&lt;br /&gt;&lt;p style="color: rgb(0, 0, 136); text-align: right;"&gt;&lt;small&gt;&lt;em&gt;Powered by&lt;/em&gt; &lt;a href="http://www.qumana.com/"&gt;Qumana&lt;/a&gt;&lt;/small&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-3343944462447192836?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/3343944462447192836/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/pharmacists-role-in-health-20.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3343944462447192836'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3343944462447192836'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/pharmacists-role-in-health-20.html' title='Pharmacists Role in Health 2.0?'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-5460156213073598900</id><published>2008-11-27T07:59:00.000-08:00</published><updated>2008-11-29T14:09:12.246-08:00</updated><title type='text'>Canary in the Coal Mine?</title><content type='html'>&lt;p&gt;PC Magazine will publish their &lt;a href="http://news.cnet.com/8301-17938_105-10102262-1.html"&gt;last print edition&lt;/a&gt; in January 2009. Even though I now read most things online, PC Magazine was alway fun to get in the mail and devour. Some print editions are just more enjoyable to read than online editions. PC Mag was one, NEJM for some reason is another. AJHP and JAMIA for unknown reasons to me just are not. I prefer to read those on line or read the individual PDFs.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;So while I morn the death of PC Magazine print edition, I wonder if this is the canary in the coal mine for print journals in general and specifically AJHP and JAMIA?&lt;/p&gt;&lt;br /&gt;&lt;p&gt;At the ASHP House of Delegates I introduced an amendment to urge AJHP have an option for online edition only. Even if it is a small percentage that choose the option, it would decrease production and prevent a ton of waste. I recently cleaned my home office, it was incredible how much AJHP made up the dump run. After some debate, the motion passed with a wide majority.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;What some some people "in the know" discussed with me (off line) was that AJHP gets a lot of revenue from the print edition. Having some choose online only would decrease the circulation numbers and potentially decrease revenue. &lt;a href="http://www.techcrunch.com/2008/11/20/iab-reports-us-online-advertising-reaches-59-billion-in-the-third-quarter/"&gt;Online advertising remains healthy&lt;/a&gt;, even in this down economy. So, part of me thinks ASHP or their advertising agent is not exploiting the online journal enough. Wouldn't be more honest with advertisers to show them that x% choose online versions only? That percentage where not looking at the print version anyway, therefore the advertisers where not getting the value they might have thought they where.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;I would like to continue to urge that AJHP have an option to receive the journal in an online version only. It would help with the environment and help keep my office less cluttered. The canary in the mine has died, it is time to take measures to insure AJHP remains healthy.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-5460156213073598900?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/5460156213073598900/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/canary-in-coal-mine.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5460156213073598900'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5460156213073598900'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/canary-in-coal-mine.html' title='Canary in the Coal Mine?'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2849755393473097195</id><published>2008-11-26T14:06:00.000-08:00</published><updated>2008-12-29T16:45:24.984-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='bcma'/><title type='text'>Nothing from nothing leaves nothing</title><content type='html'>&lt;p&gt;The previous post reminds me of the great Bill Preston tune that goes "Nothing from nothing, leaves nothing; if you gotta have something, then you need to believe in me".&lt;/p&gt;&lt;br /&gt;&lt;p&gt;The Intellidot studies add nothing to the knowledge base of BCMA. Subtracting that from nothing (no studies that document the value of BCMA) leaves us nothing.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;You need to believe is something (or a higher authority) on the value of BCMA, instead of evidenced based practice, if you believe in BCMA.&lt;/p&gt;&lt;br /&gt;&lt;p&gt;Still waiting for some study, any study, that shows it's value. I can be convinced, just waiting. Sure we need to to build systems that assume that humans are not perfect. It is just BCMA has not proven that it is the solution.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2849755393473097195?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2849755393473097195/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/nothing-from-nothing-leaves-nothing.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2849755393473097195'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2849755393473097195'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/nothing-from-nothing-leaves-nothing.html' title='Nothing from nothing leaves nothing'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-466156386688503912</id><published>2008-11-26T08:12:00.001-08:00</published><updated>2008-11-26T08:12:28.570-08:00</updated><title type='text'>Intellidot response on the ASHP list serv</title><content type='html'>&lt;p&gt;The following is a response to numerous comments from my post on the press release of 100% error reduction, that is in this blog as well.&amp;#160; I felt it responsible to post his response here as well.&lt;/p&gt;  &lt;p&gt;Thanks to everyone who submitted comments and opinions on the Nursing News article published on Nursezone.com.&amp;#160; As a member of the Section Advisory Group on Automation for the ASHP Section on Pharmacy Informatics and Technology, I certainly understand the premise of your opinions and comments.&amp;#160; I feel strongly that the Listserv should not be used by vendors to promote or defend a product or company.&amp;#160;&amp;#160; With that in mind, let me attempt to at least clarify some of the points that have been mentioned so that Listserv participants have complete and accurate information.&lt;/p&gt;  &lt;p&gt;First, most IntelliDOT customers like to do a before-and-after study surrounding the implementation of our BCMA product.&amp;#160; Sample size is typically about 250 pre-implementation transactions and 250 post-implementation transactions.&amp;#160; We advise them to follow the David Bates study methodology.&amp;#160; As stated in the article, only &lt;u&gt;serious&lt;/u&gt; errors (does not include dose timing errors or dose omissions for something like a vitamin) were counted which accounts for the small number of pre-BCMA errors.&amp;#160; I suspect like users of other BCMA vendors our customers have seen some very positive results.&amp;#160; &lt;/p&gt;  &lt;p&gt;Furthermore, the individual hospital studies were done by these hospitals to meet their internal needs, and it was not originally our intent to publish a compilation of these studies.&amp;#160; However, users of our system encouraged us to do so, so the summary results were made available at our website.&amp;#160; We have no intent to pass this article off for more than what it is which is very clearly described by the author.&amp;#160; Ron categorized it as “additional information”, which is a good description of its intent.&amp;#160; Also, the info from the various hospitals that submitted data was collected at or around their date of BCMA implementation, so it was not in any way selectively collected by the company over the four year period.&amp;#160; That said, we are going to review the wording in the posted article to make sure the intent is clearly stated.&lt;/p&gt;  &lt;p&gt;In reference to the sample size, I agree the sample size is limited although it does far exceed the sample size in the Barker-Bates study which is the largest multi-facility study to date (50 med administrations each in 36 hospitals).&amp;#160; An observation study with a much larger sample size done by an independent clinical group (ASHP or other) is a good idea.&amp;#160; Such a study that includes all BCMA vendors with results comparatively and categorically analyzed would be most valuable to pharmacists and nurses planning to implement a BCMA system.&amp;#160; We welcome such research and would be happy to participate in and support it.&lt;/p&gt;  &lt;p&gt;Reference was also made on the Listserv to “a very small bar code” that IntelliDOT uses, specifically saying it may be a potential competitive advantage.&amp;#160; In fact, IntelliDOT’s BCMA system reads all standard manufacturer bar codes as well as those applied by pharmacy packaging systems….just as I suspect other BCMA systems do.&amp;#160; The “small bar code” is probably a reference to the proprietary “DOT” symbology that IntelliDOT uses as a way for nurses to document observations and comments during administration without having to type them.&amp;#160; The DOT is not a symbol that is interchangeable with a bar code and has not been applied to medication, patients, or name badges when using IntelliDOT’s BCMA system.&amp;#160; Therefore, the benefit of the DOT lies in its application, not in how it competes with bar codes.&lt;/p&gt;  &lt;p&gt;In one of the listserv messages, the question is raised of how a system can insure that a patient wrist band - and not some other bar code - is scanned.&amp;#160; Simply stated, the bar code on the wrist band must be unique and not easily reproduced when using a BCMA system in the hospital.&amp;#160; It cannot be the same as the patient bar code that prints on hospital forms or labels.&amp;#160; There are ways to make the wrist band bar code unique and difficult to reproduce.&amp;#160; Access to the reprinting of patient wrist bands also needs to be limited, controlled and tracked.&amp;#160; In my opinion, proper management of bar coded patient wrist bands is an inherent part of a successful BCMA system, and our customers have been successful in doing it.&lt;/p&gt;  &lt;p&gt;Finally, a posted comment suggests that having the observer intervene to prevent a serious error from occurring may account for the 100% reduction in serious errors.&amp;#160; In fact, while observation of med passes was taking place, the RNs doing the observing did intervene if a serious error was about to be made.&amp;#160; This was obviously in the patient’s best interest.&amp;#160; However, these interventions only occurred during the pre-implementation phase, although the study plan also included such intervention in the post-implementation phase if it were needed to prevent a serious error.&amp;#160; In either case, the near error would be tabulated as an error, not at as accurate administration.&amp;#160; At no time was an intervention used to avoid an error when using the BCMA system to pump up the success rate of using the BCMA system.&lt;/p&gt;  &lt;p&gt;I plan to attend the ASHP meeting in Orlando and would be happy to further discuss this article and any ideas for future studies.&amp;#160; I can also be reached on my cell number below.&lt;/p&gt;  &lt;p&gt;Happy Thanksgiving to all!&lt;/p&gt;  &lt;p&gt;Thanks again,&lt;/p&gt;  &lt;p&gt;&lt;b&gt;Paul Seelinger, RPh&lt;/b&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;&lt;b&gt;Sr. Director of Clinical Operations&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;&lt;b&gt;IntelliDOT Corporation&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;&lt;i&gt;The Bedside Patient Safety Experts&lt;/i&gt;&lt;/p&gt;  &lt;p&gt;13520 Evening Creek Drive North, Suite 400&lt;/p&gt;  &lt;p&gt;San Diego, CA 92128&lt;/p&gt;  &lt;p&gt;Cell: 310-961-0630&lt;/p&gt;  &lt;p&gt;Fax: 866-212-9947&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-466156386688503912?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/466156386688503912/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/intellidot-response-on-ashp-list-serv.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/466156386688503912'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/466156386688503912'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/intellidot-response-on-ashp-list-serv.html' title='Intellidot response on the ASHP list serv'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-974235345433320409</id><published>2008-11-25T10:36:00.001-08:00</published><updated>2008-11-25T10:36:31.717-08:00</updated><title type='text'>ASHP Meeting Informatics Presentations and events</title><content type='html'>&lt;p&gt;&lt;b&gt;Sunday, December 7&lt;/b&gt;    &lt;table cellspacing="0" cellpadding="0" border="1"&gt;&lt;tbody&gt;       &lt;tr&gt;         &lt;td valign="top" width="125"&gt;           &lt;p&gt;Time&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="192"&gt;           &lt;p&gt;Event&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="172"&gt;           &lt;p&gt;Comments&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="150"&gt;           &lt;p&gt;Location&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="125"&gt;           &lt;p&gt;8:30 a.m. – 12:30 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="192"&gt;           &lt;p&gt;Workshop: Skills for Assessing Readiness for Health Information Technology Implementation             &lt;br /&gt;&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="172"&gt;           &lt;p&gt;(FYI) Workshop Fee: $85             &lt;br /&gt;Registration is limited to 60 participants.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="150"&gt;           &lt;p&gt;W304C. Level 3&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="125"&gt;           &lt;p&gt;3:00 – 5:00 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="192"&gt;           &lt;p&gt;Residency Preceptors’ Town Hall&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="172"&gt;&amp;#160;&lt;/td&gt;          &lt;td valign="top" width="150"&gt;           &lt;p&gt;Valencia W415A, Level 4&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="125"&gt;           &lt;p&gt;3:15 - 4:15 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="192"&gt;           &lt;p&gt;ASHP New Member Welcome Reception &lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="172"&gt;&amp;#160;&lt;/td&gt;          &lt;td valign="top" width="150"&gt;           &lt;p&gt;W202C, Level 2&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="125"&gt;           &lt;p&gt;5:30 – 7:00 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="192"&gt;           &lt;p&gt;ASHP Best Practices Award in Health-System Pharmacy Poster&lt;/p&gt;            &lt;p&gt;Reception&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="172"&gt;&amp;#160;&lt;/td&gt;          &lt;td valign="top" width="150"&gt;           &lt;p&gt;The Peabody Orlando Florida – Ballroom, Convention Level&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;     &lt;/tbody&gt;&lt;/table&gt; &lt;/p&gt;  &lt;p&gt;&lt;b&gt;Monday, December 8&lt;/b&gt;    &lt;table cellspacing="0" cellpadding="0" border="1"&gt;&lt;tbody&gt;       &lt;tr&gt;         &lt;td valign="top" width="127"&gt;           &lt;p&gt;Time&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="206"&gt;           &lt;p&gt;Event&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="165"&gt;           &lt;p&gt;Comments&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="140"&gt;           &lt;p&gt;Location&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="127"&gt;           &lt;p&gt;9:00 – 10:30 a.m&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="206"&gt;           &lt;p&gt;Opening General Session&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="165"&gt;&amp;#160;&lt;/td&gt;          &lt;td valign="top" width="140"&gt;           &lt;p&gt;West Hall D2, Level 2&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="127"&gt;&amp;#160;&lt;/td&gt;          &lt;td valign="top" width="206"&gt;&amp;#160;&lt;/td&gt;          &lt;td valign="top" width="165"&gt;&amp;#160;&lt;/td&gt;          &lt;td valign="top" width="140"&gt;&amp;#160;&lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="127"&gt;           &lt;p&gt;2:00 – 5:00 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="206"&gt;           &lt;p&gt;BCMA in 2008: Trends, Regulations, and Innovations&lt;/p&gt;            &lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="165"&gt;           &lt;p&gt;MPA: Robert Christiansen&lt;/p&gt;            &lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="140"&gt;           &lt;p&gt;W209A, Level 2&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="127"&gt;           &lt;p&gt;5:15 – 6:15 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="206"&gt;           &lt;p&gt;ASHP Section of Pharmacy Informatics and Technology – Barcoding Networking Session &lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="165"&gt;           &lt;p&gt;Facilitated by C. Urbanski – EC Liaison required, but other EC members optional&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="140"&gt;           &lt;p&gt;W308A, Level 3&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;     &lt;/tbody&gt;&lt;/table&gt; &lt;/p&gt;  &lt;p&gt;&lt;b&gt;Tuesday, December 9&lt;/b&gt;    &lt;table cellspacing="0" cellpadding="0" border="1"&gt;&lt;tbody&gt;       &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;Time&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;Event&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;Comments&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;Location&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;8:00 – 11:00 a.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;&lt;strong&gt;Information Technology and the Pharmacy Department: Collaboration or Conflict?&lt;/strong&gt;&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;MPA: John Poikonen&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;W209A, Level 2&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;2:00 – 5:00 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;Lessons Learned: What Health-System Pharmacists Can Learn from the VA Informatics Experience&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;MPA: Lynn Sanders&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;W209A, Level 2&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;4:30 – 7:30 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;The 3rd Annual Pharmacy Informatics Networking Event &lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;Coordinated by Kevin Marvin (non-ASHP sponsored)&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;Houlihans, 9150 International Drive, Orlando.&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;     &lt;/tbody&gt;&lt;/table&gt; &lt;/p&gt;  &lt;p&gt;&lt;b&gt;Wednesday, December 10&lt;/b&gt;    &lt;table cellspacing="0" cellpadding="0" border="1"&gt;&lt;tbody&gt;       &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;Time&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;Event&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;Comments&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;Location&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;8:00 - 9:50 AM&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;Clinical Decision Support in Pediatric and Adult Populations&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;MPA: Lolita White&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;W208A, Level 2&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;&lt;strong&gt;10:00 – 11:00 a.m.&lt;/strong&gt;&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;Spotlight on Science&lt;/p&gt;            &lt;p&gt;&lt;strong&gt;Featured Speaker:&lt;/strong&gt; Stephen G. Kaler, MD MPH              &lt;br /&gt;Clinical Director, National Institute of Child Health and Human Development,              &lt;br /&gt;National Institutes of Health              &lt;br /&gt;&lt;strong&gt;Topic:&lt;/strong&gt; Translational Medicine: Effects on Drug Development, Research, and Health-System Pharmacy&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;West Hall D2, Level 2&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;11:15 a.m. – 12:15 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;ASHP Section of Pharmacy Informatics and Technology – CPOE Networking Session&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;Facilitated by C. Hardy – EC Liaison required, but other EC members optional&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;W304F, Level 3&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;12:30 – 1:30 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;ASHP Section of Pharmacy Informatics and Technology – Informatics Residency Networking Session&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;Facilitated by D. Tjhio – EC Liaison required, but other EC members optional&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;W304F, Level 3&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;2:00 – 5:00 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;&lt;strong&gt;Informatics Bytes 2008: Pearls of Informatics&lt;/strong&gt;&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;           &lt;p&gt;MPA: Elizabeth Fields&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="141"&gt;           &lt;p&gt;W209A, Level 2&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="128"&gt;           &lt;p&gt;7:30 – 10:30 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="207"&gt;           &lt;p&gt;ASHP’s Happenin’ Street Party at Universal Studios® Florida&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="162"&gt;&amp;#160;&lt;/td&gt;          &lt;td valign="top" width="141"&gt;&amp;#160;&lt;/td&gt;       &lt;/tr&gt;     &lt;/tbody&gt;&lt;/table&gt; &lt;/p&gt;  &lt;p&gt;&lt;b&gt;Thursday, December 11&lt;/b&gt;    &lt;table cellspacing="0" cellpadding="0" border="1"&gt;&lt;tbody&gt;       &lt;tr&gt;         &lt;td valign="top" width="126"&gt;           &lt;p&gt;Time&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="208"&gt;           &lt;p&gt;Event&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="165"&gt;           &lt;p&gt;Comments&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="139"&gt;           &lt;p&gt;Location&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="126"&gt;           &lt;p&gt;10:30 AM - 12:00 PM&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="208"&gt;           &lt;p&gt;We Are the Experts: Optimizing the Pharmacist's Role in CPOE Implementation&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="165"&gt;           &lt;p&gt;MPA: Kevin Scheckelhoff&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="139"&gt;           &lt;p&gt;W204C, Level 2&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="126"&gt;           &lt;p&gt;12:00 – 2:00 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="208"&gt;           &lt;p&gt;Thursday Networking Luncheon&lt;/p&gt;            &lt;p&gt;Featured Speaker: Kevin Carroll&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="165"&gt;&amp;#160;&lt;/td&gt;          &lt;td valign="top" width="139"&gt;           &lt;p&gt;Valencia W415C, Level 4&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;        &lt;tr&gt;         &lt;td valign="top" width="126"&gt;           &lt;p&gt;2:00 – 4:00 p.m.&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="208"&gt;           &lt;p&gt;Using Informatics and Basic Research to Improve Medication Safety&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="165"&gt;           &lt;p&gt;MPA: Heidi Cozart&lt;/p&gt;         &lt;/td&gt;          &lt;td valign="top" width="139"&gt;           &lt;p&gt;W207A, Level 2&lt;/p&gt;         &lt;/td&gt;       &lt;/tr&gt;     &lt;/tbody&gt;&lt;/table&gt;&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-974235345433320409?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/974235345433320409/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/ashp-meeting-informatics-presentations.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/974235345433320409'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/974235345433320409'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/ashp-meeting-informatics-presentations.html' title='ASHP Meeting Informatics Presentations and events'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-1063365078638903957</id><published>2008-11-24T09:23:00.001-08:00</published><updated>2008-11-24T09:23:28.305-08:00</updated><title type='text'>McKesson agrees to $350 million settlement</title><content type='html'>&lt;p&gt;Below is another piece from Modern Healthcare.&amp;#160; Wow, $350M is a lot to say “I did nothing.”&lt;/p&gt;  &lt;p&gt;-----------------------------------------------------------&lt;/p&gt;  &lt;p&gt;Pharmaceutical distributor McKesson Corp. announced it would pay $350 million to settle a class-action lawsuit &lt;a href="http://e.ccialerts.com/a/hBJKt1WAIyhSgAa0kNPApm-t8eg/cdb8"&gt;&lt;u&gt;alleging&lt;/u&gt;&lt;/a&gt; the company conspired with First DataBank to inflate drug prices paid by consumers and third-party payers. &lt;/p&gt;  &lt;p&gt;In a conference call, Chairman and Chief Executive Officer John Hammergren was adamant that the allegations are false. “We did not manipulate drug prices and did not violate any laws,” Hammergren said. &lt;/p&gt;  &lt;p&gt;“McKesson has denied and continues to deny each and all of the claims and contentions alleged in the class action, and has denied and continues to deny that it has committed any violation of law or engaged in any wrongful act alleged, or that could have been alleged, in the class action,&amp;quot; the settlement said. &lt;/p&gt;  &lt;p&gt;According to the complaint brought by the New England Carpenters Health Benefits Fund, McKesson and First DataBank in 2001 allegedly came up with a scheme to “artificially raise and fix” the spread between wholesale average costs and average wholesale prices published by First DataBank, violating the Racketeer Influenced and Corrupt Organization Act. An antitrust lawsuit based on the same allegations was dismissed in August. &lt;/p&gt;  &lt;p&gt;The agreement remains subject to approval by the U.S. District Court in Boston, and it does not dispose of similar lawsuits brought by federal, state and local agencies. McKesson has set aside a reserve fund of $143 million for those claims, which the company likewise denies. Executive Vice President and Chief Financial Officer Jeff Campbell said that he expected the total pre-tax charge of $493 million to swing the company to a loss in its third quarter, which ends Dec. 31. &lt;/p&gt;  &lt;p&gt;First DataBank reached a separate settlement agreement in 2006 and amended it in May 2008, agreeing to pay $1 million and reduce the markup factor for many drugs in its list. A hearing for final approval of that agreement is set for Dec. 17. &lt;i&gt;— &lt;a href="mailto:gblesch@crain.com"&gt;&lt;u&gt;&lt;i&gt;Gregg Blesch / HITS staff writer&lt;/i&gt;&lt;/u&gt;&lt;/a&gt;&lt;/i&gt;&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-1063365078638903957?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/1063365078638903957/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/mckesson-agrees-to-350-million.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1063365078638903957'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/1063365078638903957'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/mckesson-agrees-to-350-million.html' title='McKesson agrees to $350 million settlement'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-5172031282497448248</id><published>2008-11-24T09:19:00.001-08:00</published><updated>2008-11-24T09:19:42.840-08:00</updated><title type='text'>Mediware purchases Hann's On for $3.5 million</title><content type='html'>&lt;p&gt;Below is a posting from Modern Healthcare.&amp;#160; Phil Hann is one of the all time great guys in the industry.&amp;#160; He belongs in the Pharmacy Informatics Hall of Fame and deserves 10 times, heck 100x this amount.&amp;#160; He was my boss back in the day;&amp;#160; When he was a victim of a Corporate downsizing, he put it all on the line to follow his dream and started a pharmacy information system company.&amp;#160;&amp;#160; His product was as elegant and brilliant as he is.&amp;#160; I hope Phil does not ride off into the sunset on his Harley for too long as we need him in the profession.&amp;#160; All the best to everyone at Hanns On!&lt;/p&gt;  &lt;p&gt;-------------------------------------------------------------&lt;/p&gt;  &lt;p&gt;Mediware Information Systems acquired nearly all the assets of Hann’s On Software in a $3.5 million cash agreement. &lt;/p&gt;  &lt;p&gt;The Lenexa, Kan.-based developer of software systems for blood and medication management will use Santa Rosa, Calif.-based Hann’s On products to grow its medication-management offerings. The purchase will allow Mediware to expand its focus on smaller hospitals, alternate-site infusion and specialty-pharmacy markets, according to a news release. The deal includes an additional earning opportunity based on operational performance&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-5172031282497448248?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/5172031282497448248/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/mediware-purchases-hann-on-for-35.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5172031282497448248'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5172031282497448248'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/mediware-purchases-hann-on-for-35.html' title='Mediware purchases Hann&amp;#39;s On for $3.5 million'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-3355617855586379078</id><published>2008-11-23T10:59:00.000-08:00</published><updated>2008-11-23T11:03:30.313-08:00</updated><title type='text'>Levels of Security on pharmacy informatics</title><content type='html'>The Pentagon just recently banned computer flash drives due to virus threats on the various netwroks.  We see in hospital systems today many "worms" and virus entering the overall networks - only having it necessary to shut down thew systems and resorting to the old paper systems until the systems are up and running.  I think a study of measuring medication errors during these times of "technology down time" might be interesting to track and whether these errors are more profound than the ones we were used to seeing when eveything was on paper overall and steps were in place to dispense with the paper trails.  I think having a mixed system of computer versus paper might be more detrimental in the long term.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-3355617855586379078?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/3355617855586379078/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/levels-of-security-on-pharmacy.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3355617855586379078'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3355617855586379078'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/levels-of-security-on-pharmacy.html' title='Levels of Security on pharmacy informatics'/><author><name>Rita</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6299996098282276939</id><published>2008-11-21T14:38:00.001-08:00</published><updated>2008-11-21T14:38:50.366-08:00</updated><title type='text'>Why a pharmacy informatics blog?</title><content type='html'>&lt;p&gt;What is needed is a pharmacy informatics blog of general interest news, views and discussion. List serv’s, while useful are not the right medium for some things, nor is a traditional web site.&lt;/p&gt;  &lt;p&gt;AMIA will be rolling out some blog and Wiki tools for members. Some topics beg for a wider audience than only an AMIA list serv, blog or wiki. So…. I have set up the following blogs for such things.&lt;/p&gt;  &lt;p&gt;&lt;a href="http://pharmacyinformatics.blogspot.com/"&gt;http://pharmacyinformatics.blogspot.com/&lt;/a&gt;&lt;/p&gt;  &lt;p&gt;&lt;a href="http://pharmacyinformatics.wordpress.com"&gt;http://pharmacyinformatics.wordpress.com&lt;/a&gt;&lt;/p&gt;  &lt;p&gt;The intent of a blog would be for a finite number of high quality contributors to regularly submit items of interest to the entire pharmacy informatics community. I have seeded some entries for examples. The intent would be that few can post and anyone could comment, although it has been recommended to me by others that moderating comments is a good idea.&lt;/p&gt;  &lt;p&gt;The intent would be that a designee from each of the major pharmacy organizations have a contributor to the blog.&amp;#160; Some have been contacted and are in process.&amp;#160; Again, the intent is that we have small number (less than 10) quality contributors. As AMIA, ASHP, HIMSS and others change committees, presumably a new fresh set of contributors would participate. Anyone would be able to comments to a blog post.&lt;/p&gt;  &lt;p&gt;Not sure Blogger or WordPress is the best platform, but it will work for a proof of concept and get the ball rolling.&lt;/p&gt;  &lt;p&gt;So, in summary the pharmacy informatics community should have the following resources:&lt;/p&gt;  &lt;ul&gt;   &lt;li&gt;Organizational specific collaboration via list servs, wikis and blogs.&lt;/li&gt;    &lt;li&gt;Non organizational specific forum for expressing views by leaders in PI, that disseminates information, news and commentary for the benefit of the entire pharmacy informatics community.&lt;/li&gt; &lt;/ul&gt;  &lt;p&gt;Please let me know your thoughts on a PI centric blog and if you would like to be a contributor.&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6299996098282276939?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6299996098282276939/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/why-pharmacy-informatics-blog.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6299996098282276939'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6299996098282276939'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/why-pharmacy-informatics-blog.html' title='Why a pharmacy informatics blog?'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2555671925179430163</id><published>2008-11-18T13:23:00.000-08:00</published><updated>2008-11-18T13:24:10.276-08:00</updated><title type='text'>eRx in California</title><content type='html'>Need to read this to see if interoperability with the pharmacy systems is addressed -jp&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Getting Connected: The Outlook for Electronic Prescribing in California &lt;/span&gt;&lt;br /&gt;Manatt Health Solutions&lt;br /&gt;November 2008&lt;br /&gt;&lt;br /&gt;The benefits of transmitting prescriptions electronically, rather than through paper transactions, have been shown to increase efficiency, lower costs, and do a better job of protecting patients from dangerous drug interactions and other medical errors. So why isn't the technology being used more widely, and what can be done to promote its adoption?&lt;br /&gt;&lt;br /&gt;This issue brief assesses the technology's progress in California and examines how greater coordination between providers, health plans, and pharmacies could help overcome persistent barriers. It reviews efforts at the state and federal level to promote e-prescribing through regulation and other incentives, as well as the development of data standards and other cooperative infrastructure needed to make it a viable alternative to paper methods.&lt;br /&gt;&lt;br /&gt;The authors conclude that accelerating the adoption of e-prescribing will require a coordinated effort on multiple fronts, including advocacy and education among California policymakers, the intelligent alignment of industry incentives, and easy access to technology tools and technical incentives.&lt;br /&gt;&lt;br /&gt;The complete issue brief is available under Document Downloads below.&lt;br /&gt;&lt;br /&gt;Document Downloads&lt;br /&gt;&lt;a href="http://www.chcf.org/topics/download.cfm?pg=chronicdisease&amp;amp;fn=E%2DPrescribingOutlookCalifornia%2Epdf&amp;amp;pid=511294&amp;amp;itemid=133793"&gt;&lt;br /&gt;Getting Connected: The Outlook for Electronic Prescribing in California&lt;/a&gt; (547K)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2555671925179430163?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2555671925179430163/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/erx-in-california.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2555671925179430163'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2555671925179430163'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/erx-in-california.html' title='eRx in California'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4829658210696738496</id><published>2008-11-13T08:17:00.000-08:00</published><updated>2008-11-13T08:30:08.415-08:00</updated><title type='text'>100% reduction in errors?</title><content type='html'>&lt;p class="MsoNormal" style="margin-left:.5in"&gt;&lt;span class="Apple-style-span" style=" "&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;A&lt;/span&gt;&lt;span class="apple-converted-space"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.nursezone.com/Nursing-News-Events/more-news.aspx?ID=18470"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;new study&lt;/span&gt;&lt;/a&gt;&lt;span class="apple-converted-space"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;posts some astonishing results.  Some thoughts: &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=" ;color:black;"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;It was sponsored and is being trumpeted by a BCMA Vendor.&lt;/span&gt;&lt;span style="mso-spacerun:yes"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;  &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;The potential for internal bias is high. &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Although all studies of new drugs come from manufactures of the drug, they need to adhere to FDA scrutiny. It would be great to have this study come under peer review.&lt;/span&gt;&lt;span style="mso-spacerun:yes"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;  &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span class="Apple-style-span" style=" "&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;If anyone has contact info or pull with Intellidot, they should be encouraged to submit it to a peer review journal. &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span class="Apple-style-span" style=" "&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;39 incidents out of 2,389 observations averted does not seem like a lot to me (1.6%).&lt;/span&gt;&lt;span style="mso-spacerun:yes"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;  &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;Although the argument is that if it was you or your child involved you would want the BCMA technology.&lt;/span&gt;&lt;span style="mso-spacerun:yes"&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;  &lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;It would also be interesting to calculate the ROI per incident avoided.&lt;/span&gt;&lt;/span&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;/p&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-size: medium;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4829658210696738496?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4829658210696738496/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/100-reduction-in-errors.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4829658210696738496'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4829658210696738496'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/11/100-reduction-in-errors.html' title='100% reduction in errors?'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-3791280842044928344</id><published>2008-10-29T14:42:00.001-07:00</published><updated>2008-10-29T14:42:54.390-07:00</updated><title type='text'>New BCMA study</title><content type='html'>&lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:&amp;quot;Courier New&amp;quot;"&gt;This BCMA study (link and abstract below) is very well done.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Unfortunately, it does not advance the notion that BCMA decreases medication errors, IMHO.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Here is my assessment, what is yours?&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span class="Apple-style-span" style="font-family: Verdana; font-size: 13px; "&gt;The key issue that goes unanswered here is the value of BCMA over an electronic MAR (eMAR).&lt;/span&gt;&lt;br /&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span class="Apple-style-span" style="font-family: Verdana; font-size: 13px; "&gt;The errors that may decrease with the use of an eMAR without BCMA needs to be considered when extolling the virtues of BCMA.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;BCMA over the use of an eMAR is still of questionable value, from the results of this study.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;The cost in time, materials and implementation of eMAR to BCMA is huge.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;The benefit according to this study is negligible.&lt;/span&gt;&lt;br /&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span class="Apple-style-span" style="font-family: Verdana; font-size: 13px; "&gt;The pre-study was with paper MARs.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Then an eMAR with BCMA capabilities was implemented. &lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;One of the largest benefits noted was a decrease in omitted dose errors. &lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;I would suggest that using an eMAR alone would help with omitted doses. BCMA does nothing to prevent these types of errors.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;An eMAR with the use of scheduling, work lists and reminders would presumably help decrease omitted dose errors. The study conclusions would be invalid if omitted dose errors where excluded in the targeted preventable ADEs calculation.&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;Therefore I conclude that the benefit of BCMA over eMAR in this study is zero.&lt;/span&gt;&lt;br /&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;"&gt;&lt;o:p&gt; &lt;span class="Apple-style-span" style="font-family: Verdana; "&gt;&lt;a href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6WKR-4TJC0MG-7&amp;amp;_user=115184&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=115184&amp;amp;md5=38e01ddfc0ce57df1503030ddd8a1095"&gt;Effectiveness of a Barcode Medication Administration System in Reducing Preventable Adverse Drug Events in a Neonatal Intensive Care Unit: A Prospective Cohort Study.&lt;/a&gt;&lt;/span&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:&amp;quot;Courier New&amp;quot;"&gt;&lt;o:p&gt; &lt;span class="Apple-style-span" style="font-family: Georgia; font-size: 16px; "&gt;&lt;span style="font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:&amp;quot;Courier New&amp;quot;"&gt;Department of Pediatrics, Roy J. and Lucille A. Carver College of Medicine; University of Iowa, the University of Iowa Hospitals and Clinics; University of Iowa Children's Hospital Iowa City, IA&lt;/span&gt;&lt;span style="font-size:10.0pt; font-family:&amp;quot;Courier New&amp;quot;"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;"&gt;&lt;o:p&gt; &lt;span class="Apple-style-span" style="font-family: Verdana; "&gt;OBJECTIVE: Patients are at risk of harm from medication errors. Barcode medication administration (BCMA) systems are recommended to mitigate preventable adverse drug events (ADEs). Our hypothesis was that a BCMA system would reduce preventable ADEs by 45% in a neonatal intensive care unit.&lt;/span&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:&amp;quot;Courier New&amp;quot;"&gt;&lt;o:p&gt; STUDY DESIGN: We conducted a prospective, observational, cohort study of a BCMA system intervention in a neonatal intensive care unit. Participants were admitted neonates during 50 weeks. Medication errors and potential or preventable ADEs were detected by a daily structured audit of each subject's medical record, with assignment of an event as a preventable ADE made by blinded assessors. The generalized estimating equation method was used in modeling the targeted, preventable ADE rate with covariates.&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:&amp;quot;Courier New&amp;quot;"&gt;&lt;o:p&gt; RESULTS: A total of 92 398 medication doses were administered to 958 subjects. The generalized estimating equation method yielded a relative risk of preventable ADE when the system was implemented of 0.53 (95% confidence limits 0.29 to 0.91, P = .04), adjusted for log(10)doses of medication/subject/day, a significant predictive covariate (P &lt; .001), as well as for birth weight, sex, Caucasian race, birth cohort number, and nursing hours/subject/day.&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span style="font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:&amp;quot;Courier New&amp;quot;"&gt;&lt;o:p&gt; CONCLUSION: The BCMA system reduced the risk of targeted, preventable ADEs by 47%, controlling for the number of medication doses/subject/day, an important risk exposure.&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-layout-grid-align:none;text-autospace:none"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;"&gt;&lt;o:p&gt; PMID: 18823912 [PubMed - as supplied by publisher] &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-3791280842044928344?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/3791280842044928344/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/10/new-bcma-study.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3791280842044928344'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/3791280842044928344'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/10/new-bcma-study.html' title='New BCMA study'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4652815191800931794</id><published>2008-10-29T10:56:00.000-07:00</published><updated>2008-10-29T10:58:48.377-07:00</updated><title type='text'>Health 2.0 Opportunities</title><content type='html'>&lt;!-- Converted from text/rtf format --&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;Wondering what opportunities exist for pharmacy applications in a Health/Medicine/Web 2.0 world&lt;/FONT&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;?&lt;/FONT&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;B&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;B&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;Reporter's notebook: Money woes don't slow Health 2.0 &lt;/FONT&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;By:&lt;/FONT&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt; &lt;/SPAN&gt;&lt;A HREF="mailto:rvesely@crain.com"&gt;&lt;SPAN LANG="en-us"&gt;&lt;I&gt;&lt;/I&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;I&gt;&lt;U&gt;&lt;FONT COLOR="#0000FF" SIZE=2 FACE="Verdana"&gt;Rebecca Vesely / HITS staff writer&lt;/FONT&gt;&lt;/U&gt;&lt;/I&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;Posted: October 28, 2008 - 5:59 am EDT&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;BR&gt; &lt;FONT SIZE=2 FACE="Verdana"&gt;No question about it. Health 2.0 is here to stay.&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;&amp;nbsp;This was plain to see at the second-annual Health 2.0 conference in San Francisco. The evidence wasn't necessarily in the presentations, but what people were doing during them. Gone were the flip-phones and cumbersome PDAs of last year. There even seemed to be fewer laptop computer users (despite a doubled attendance to about 1,000 people).&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;&amp;nbsp;Instead, conference-goers sat in darkened halls thumbing on their iPhones and slimmer-than-ever BlackBerrys.&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;&amp;nbsp;In healthcare, there's much talk about the medical home. But what if the medical home is in the palm of your hand?&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;&amp;nbsp;&amp;#8220;We're just at the beginning of mobile healthcare,&amp;#8221; said Alan Greene, a pediatrician and chief of future health of Atlanta-based ADAM, a company developing consumer health applications for Google Health and the iPhone, among other platforms. &amp;#8220;Which means we are just at the beginning of patient-centered medicine&amp;#8212;to do it where they are.&amp;#8221;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;&amp;nbsp;The Health 2.0 conference, held at the Marriott in downtown San Francisco on Oct. 22 and 23, drew lots of technology startups and venture capitalists, a few health plans and even fewer providers and employers.&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=2 FACE="Verdana"&gt;&amp;nbsp;Engaging consumers and getting them to trust the technology were key themes at the confab.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;BR&gt; &lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;A NAME=""&gt;&lt;SPAN LANG="en-us"&gt;&lt;FONT SIZE=1 FACE="Verdana"&gt;John Poikonen, Pharm.D. | Director of Clinical Informatics| UMass Memorial&amp;nbsp;Medical Center |508-334-1159 | 978-501-4887 (cell) | john.poikonen@umassmemorial.org&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;P DIR=LTR&gt;&lt;SPAN LANG="en-us"&gt;&lt;/SPAN&gt;&lt;/P&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4652815191800931794?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4652815191800931794/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/10/health-20-opportunities.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4652815191800931794'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4652815191800931794'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/10/health-20-opportunities.html' title='Health 2.0 Opportunities'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-6913732304952355373</id><published>2008-10-27T12:10:00.001-07:00</published><updated>2008-10-27T12:10:43.009-07:00</updated><title type='text'>CMS ePrescribing Conference</title><content type='html'>&lt;h1&gt;CMS ePrescribing Conference&lt;/h1&gt;  &lt;p class="MsoNormal"&gt;If you would have told me there would be ~1,500 people gathering from around the country on ePrescribing with multiple Governors, a Senator and CMS officials only 2,3, or 4 years ago, I would have said you where nuts. &lt;/p&gt;  &lt;p class="MsoNormal"&gt;The media coverage is below, here is my spin.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;First with all of the vendors, people and press it was a very energizing place.&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;Our Governor Deval Patrick gave some prepared opening remarks that seemed kind of canned.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;The Governor of the &lt;st1:place st="on"&gt;&lt;st1:placetype st="on"&gt;Island&lt;/st1:placetype&gt; of &lt;st1:placename st="on"&gt;Rhode&lt;/st1:placename&gt;&lt;/st1:place&gt;, Donald Carcieri followed.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;He was much more conversational; rarely referring to notes and seemed to me have more ‘skin in the game’.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Someone must have slipped him a note “Senator Kerry is not coming (death in the Bidden family), talk for as long as you possibly can”.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;He did.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Most speakers (and questioners) wandered off to more grandeur themes and topics.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Some highlights:&lt;/p&gt;  &lt;ul style="margin-top:0in" type="disc"&gt;  &lt;li class="MsoNormal" style="mso-list:l0 level1 lfo1;tab-stops:list .5in"&gt;&lt;st1:place st="on"&gt;&lt;st1:state st="on"&gt;Massachusetts&lt;/st1:state&gt;&lt;/st1:place&gt; is      the “caddle for eHealth Reform” as the #1 ePrescribing state in the      country.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;&lt;/li&gt;  &lt;ul style="margin-top:0in" type="circle"&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;4       million or 14% of total prescriptions are electronic.&lt;/li&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;We       have also secured a Medicaid wavier to continue our health insurance       mandate.&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;&lt;/li&gt;   &lt;ul style="margin-top:0in" type="square"&gt;    &lt;li class="MsoNormal" style="mso-list:l0 level3 lfo1;tab-stops:list 1.5in"&gt;Given        that Deval and Barrack are buddies this may be the national template        sooner not later.&lt;/li&gt;   &lt;/ul&gt;  &lt;/ul&gt;  &lt;li class="MsoNormal" style="mso-list:l0 level1 lfo1;tab-stops:list .5in"&gt;&lt;st1:place st="on"&gt;&lt;st1:state st="on"&gt;Rhode Island&lt;/st1:state&gt;&lt;/st1:place&gt; has      been flip flopping with the Commonwealth on being #1 for the last few      years.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;But hey they only 30 miles X      40 miles of territory to deal with.&lt;/li&gt;  &lt;ul style="margin-top:0in" type="circle"&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;Over       the last 3 months 20% of the Rxs are eRx’s and should be #1 next year.&lt;/li&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;The       Social Security problem is easy.&lt;span style="mso-spacerun:yes"&gt;        &lt;/span&gt;It is actuarial.&lt;span style="mso-spacerun:yes"&gt;        &lt;/span&gt;Politically&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;it is a bitch,       but the solution is quite easy.&lt;/li&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;Healthcare       reform and payment is very, very difficult.&lt;/li&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;HIT       is key (you all understand this)&lt;/li&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;RI       has a cool public-private health information exchange in the works.&lt;/li&gt;  &lt;/ul&gt;  &lt;li class="MsoNormal" style="mso-list:l0 level1 lfo1;tab-stops:list .5in"&gt;Kevin      Marvin, Pharmacy Informatics Guru, slips me a note on his solution to world      peace or at least drug cost savings:&lt;/li&gt;  &lt;ul style="margin-top:0in" type="circle"&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;Eliminate       Medicaid Rebates&lt;/li&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;Eliminate       Direct to Consumer adds&lt;/li&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;Adopt       RxNorm as a standard (it was some other more articulate statement, but       that is what I interrupted and remember)&lt;/li&gt;  &lt;/ul&gt;  &lt;li class="MsoNormal" style="mso-list:l0 level1 lfo1;tab-stops:list .5in"&gt;Secretary      Levitt of HHS has a very good story about the demise of &lt;st1:country-region st="on"&gt;&lt;st1:place st="on"&gt;Argentina&lt;/st1:place&gt;&lt;/st1:country-region&gt;      and the potential road to ruin we are on.&lt;span style="mso-spacerun:yes"&gt;       &lt;/span&gt;My take away:&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;do not let the      RPh license lapse, it might get really ugly on a economic scale. &lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;On a positive not the connection with      cell phone and Airlines was upbeat.&lt;/li&gt;  &lt;ul style="margin-top:0in" type="circle"&gt;   &lt;li class="MsoNormal" style="mso-list:l0 level2 lfo1;tab-stops:list 1.0in"&gt;Way       to deal with Change&lt;/li&gt;   &lt;ul style="margin-top:0in" type="square"&gt;    &lt;li class="MsoNormal" style="mso-list:l0 level3 lfo1;tab-stops:list 1.5in"&gt;Fight        it&lt;/li&gt;    &lt;li class="MsoNormal" style="mso-list:l0 level3 lfo1;tab-stops:list 1.5in"&gt;Accept&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;it&lt;/li&gt;    &lt;li class="MsoNormal" style="mso-list:l0 level3 lfo1;tab-stops:list 1.5in"&gt;Lead        it&lt;/li&gt;   &lt;/ul&gt;  &lt;/ul&gt; &lt;/ul&gt;  &lt;p class="MsoNormal"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/p&gt;  &lt;ul style="margin-top:0in" type="disc"&gt;  &lt;li class="MsoNormal" style="mso-list:l0 level1 lfo1;tab-stops:list .5in"&gt;Session      Highlights&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;(see Slide Links below)&lt;/li&gt;  &lt;li class="MsoNormal" style="mso-list:l0 level1 lfo1;tab-stops:list .5in"&gt;CMS      has all Plan formularies in a codified manner for a nominal fee per Tracey      McCutcheon, Deputy Director of Medicare Drug Benefit and C&amp;amp;D Data      Group, Center for Drug and Health Plan Choice.&lt;/li&gt; &lt;/ul&gt;  &lt;p class="MsoNormal"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/p&gt;  &lt;h3&gt;Press coverage &lt;/h3&gt;  &lt;p class="MsoNormal"&gt;&lt;a href="http://news.bostonherald.com/business/general/view/2008_10_08_Confab_pushes_%E2%80%98e-prescribing_:_Tool_may_stop_harmful_drug_mixing/srvc=home&amp;amp;position=also"&gt;Boston Herald&lt;/a&gt; ..&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;a href="http://commonhealth.wbur.org/guest-contributors/2008/10/the-value-of-e-prescribing-by-kerry-weems/"&gt;Local NPR (WBUR)&lt;/a&gt; ..&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;a href="http://www.govhealthit.com/online/news/350605-1.html"&gt;Government Health IT&lt;/a&gt; ..&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;a href="http://www.healthcareitnews.com/story.cms?id=10170&amp;amp;fromRSS=true"&gt;Healthcare IT News&lt;/a&gt; ..&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;a href="http://www.thebostonchannel.com/health/17636500/detail.html"&gt;Local TV Coverage&lt;/a&gt; ..&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;Map of States and ePrescribing rates &lt;&lt;a href="http://www.surescripts.com/images/2008_map_nation.jpg" title="http://www.surescripts.com/images/2008_map_nation.jpg"&gt;&lt;span style="font-size:10.0pt;font-family:Arial"&gt;http://www.surescripts.com/images/2008_map_nation.jpg&lt;/span&gt;&lt;/a&gt;&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/p&gt;  &lt;h1&gt;Slide of all sessions!&lt;/h1&gt;  &lt;h1&gt;&lt;a href="http://www.e-prescribeconference.com/"&gt;&lt;span style="color:windowtext; text-decoration:none;text-underline:none"&gt;http://www.e-prescribeconference.com&lt;/span&gt;&lt;/a&gt;&lt;/h1&gt;  &lt;p class="MsoNormal"&gt;&lt;u&gt;&lt;span style="color:blue"&gt;&lt;o:p&gt;&lt;span style="text-decoration:  none"&gt; &lt;/span&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-6913732304952355373?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/6913732304952355373/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/10/cms-eprescribing-conference.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6913732304952355373'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/6913732304952355373'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/10/cms-eprescribing-conference.html' title='CMS ePrescribing Conference'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-5173539534179085815</id><published>2008-10-06T07:40:00.001-07:00</published><updated>2008-10-06T07:45:31.954-07:00</updated><title type='text'>RxNorm and Routed Generics</title><content type='html'>The concept of a routed generic as the atomic level of a medication in EHRs, PHRs, CPOE and ACPOE systems is popular.  It is becoming a larger issue with Med Rec.  For example, I know I take oral fish oil, but I can never remember the exact strength.  So identification of the drug (and route) is common for people to state.&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;One of the problems with RxNorm is that there is not explict support for this concept.&lt;/div&gt;&lt;div&gt;&lt;ul&gt;&lt;li&gt;Do we need to ask the NLM for more support for this concept?&lt;br /&gt;&lt;/li&gt;&lt;li&gt;Is there an easy SQL fix to this issue in the data structure?&lt;br /&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Any input is appreciated.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-5173539534179085815?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/5173539534179085815/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/10/rxnorm-and-routed-generics.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5173539534179085815'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/5173539534179085815'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/10/rxnorm-and-routed-generics.html' title='RxNorm and Routed Generics'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-2226548064983933854</id><published>2008-09-30T19:25:00.000-07:00</published><updated>2008-09-30T19:28:32.116-07:00</updated><title type='text'></title><content type='html'>&lt;p class="MsoNormal" style="margin: 0in 0in 0pt; text-indent: 0.25in;"&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;AHRQ’s new teleconference on  Clinical Decision Support &lt;/span&gt;&lt;/p&gt; &lt;p class="MsoNormal" style="margin: 0in 0in 0pt 0.25in;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;  &lt;/span&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/strong&gt;&lt;/p&gt; &lt;ul style="margin-top: 0in;" type="disc"&gt;&lt;li class="MsoNormal" style="margin: 0in 0in 0pt;"&gt;&lt;i&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;October 27, 2008, from 2:30 pm –  4:00 pm Eastern Time&lt;/span&gt;&lt;/i&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;   &lt;/span&gt; &lt;/li&gt;&lt;li class="MsoNormal" style="margin: 0in 0in 0pt;"&gt;&lt;i&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;Moderator: Jon White, Agency for  Healthcare Research and Quality &lt;/span&gt;&lt;/i&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;  &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt; &lt;/li&gt;&lt;li class="MsoNormal" style="margin: 0in 0in 0pt;"&gt;&lt;i&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;Presenters: &lt;/span&gt;&lt;/i&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; color: black; font-family: Symbol;"&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; color: black; font-family: Symbol;"&gt;&lt;span style=""&gt;&lt;span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;i&gt;&lt;span style="font-size: 10pt; color: black; font-family: Arial;"&gt;&lt;/span&gt;&lt;/i&gt;&lt;/li&gt;&lt;/ul&gt;    &lt;span style="font-size: 10pt; color: black; font-family: Symbol;"&gt;&lt;/span&gt;&lt;p class="MsoNormal" style="margin: 0in 0in 0pt 1.25in; text-indent: -0.25in;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: Symbol;"&gt;&lt;span style=""&gt;·&lt;span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"&gt;          &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;i&gt;&lt;span style="font-size: 10pt; color: black; font-family: Arial;"&gt;Ben-Tzion Karsh,  Ph.D.,&lt;/span&gt;&lt;/i&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt; &lt;i&gt;&lt;span style="color: black;"&gt;&lt;st1:place st="on"&gt;&lt;st1:placetype st="on"&gt;University&lt;/st1:placetype&gt; of &lt;st1:placename st="on"&gt;Wisconsin&lt;/st1:placename&gt;&lt;/st1:place&gt; Department of Industrial and  Systems Engineering&lt;/span&gt;&lt;/i&gt; &lt;i&gt;&lt;span style="color: black;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p class="MsoNormal" style="margin: 0in 0in 0pt 1.25in; text-indent: -0.25in;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: Symbol;"&gt;&lt;span style=""&gt;·&lt;span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"&gt;          &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;i&gt;&lt;span style="font-size: 10pt; color: black; font-family: Arial;"&gt;Ross Koppel,  Ph.D., &lt;/span&gt;&lt;/i&gt;&lt;em&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;University of  Pennsylvania&lt;/span&gt;&lt;/em&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;  &lt;i&gt;Department of Sociology, and Center for Clinical Epidemiology and  Biostatistics, School of Medicine&lt;span style="color: black;"&gt;  &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p class="MsoNormal" style="margin: 0in 0in 0pt 1.25in; text-indent: -0.25in;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: Symbol;"&gt;&lt;span style=""&gt;·&lt;span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"&gt;          &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;i&gt;&lt;span style="font-size: 10pt; color: black; font-family: Arial;"&gt;David F. Lobach, M.D.,  Ph.D., Division of Clinical Informatics, Department of Community and Family  Medicine, Duke University&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="margin: 0in 0in 0pt 1.25in; text-indent: -0.25in;"&gt;&lt;i&gt;&lt;span style="font-size: 10pt; color: black; font-family: Arial;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/i&gt; &lt;/p&gt;&lt;ul style="margin-top: 0in;" type="disc"&gt;&lt;li class="MsoNormal" style="margin: 0in 0in 0pt;"&gt;&lt;i&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;Sponsored by the &lt;st1:place st="on"&gt;&lt;st1:placename st="on"&gt;AHRQ&lt;/st1:placename&gt; &lt;st1:placename st="on"&gt;National&lt;/st1:placename&gt; &lt;st1:placename st="on"&gt;Resource&lt;/st1:placename&gt; &lt;st1:placetype st="on"&gt;Center&lt;/st1:placetype&gt;&lt;/st1:place&gt; for Health IT&lt;/span&gt;&lt;/i&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt; &lt;br /&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;&lt;p class="MsoNormal" style="margin: 0in 0in 0pt 0.25in;"&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;This is the second in a series of  four free 90-minute Web conferences over the next few months that will focus on  how clinical decision support—a clinical system, application, or process that  helps health professionals make good patient care decisions—can be used to  inform and improve health care delivery. Featured presenters are Ben-Tzion  Karsh, Ph.D., M. S. I. E., University of Wisconsin Department of Industrial  Engineering and Systems; Ross Koppel, Ph.D., University of Pennsylvania  Department of Sociology, and Center for Clinical Epidemiology and Biostatistics,  School of Medicine; and David F. Lobach, M.D., Ph.D., Division of Clinical  Informatics, Department of Community and Family Medicine, Duke University. They  will discuss existing evidence about the relationship between CDS and workflow,  levels and stages, including findings regarding order sets and alerts, specific  CDS implementations, their impact on workflow and share lessons learned from  those implementations. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt; &lt;p class="MsoNormal" style="margin: 0in 0in 0pt 0.25in;"&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt; &lt;/p&gt; &lt;p class="MsoNormal" style="margin: 0in 0in 0pt 0.25in;"&gt;&lt;span style="font-size: 10pt; font-family: Arial;"&gt;Select to &lt;a title="blocked::https://norcevents.webex.com/mw0305l/mywebex/default.do?nomenu=true&amp;amp;siteurl=norcevents&amp;amp;service=6&amp;amp;main_url=https://norcevents.webex.com/ec0600l/eventcenter/event/eventAction.do?theAction=detail&amp;amp;confViewID=278082941&amp;amp;siteurl=norcevents&amp;amp;&amp;amp;&amp;amp;" href="https://norcevents.webex.com/mw0305l/mywebex/default.do?nomenu=true&amp;amp;siteurl=norcevents&amp;amp;service=6&amp;amp;main_url=https%3A%2F%2Fnorcevents.webex.com%2Fec0600l%2Feventcenter%2Fevent%2FeventAction.do%3FtheAction%3Ddetail%26confViewID%3D278082941%26siteurl%3Dnorcevents%26%26%26"&gt;register&lt;/a&gt; for  the Web conference.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-2226548064983933854?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/2226548064983933854/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/09/ahrqs-new-teleconference-on-clinical.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2226548064983933854'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/2226548064983933854'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/09/ahrqs-new-teleconference-on-clinical.html' title=''/><author><name>PharmIT</name><uri>http://www.blogger.com/profile/09964702373871253774</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-4339359997070293680</id><published>2008-09-26T09:46:00.000-07:00</published><updated>2008-09-26T10:20:11.739-07:00</updated><title type='text'>CPOE v BCMA</title><content type='html'>There was a thread on this in the AMIA Pharmacoinformatics list serv.&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Today, there was a very good teleconference with David Bates and Robert Wachter where the moderator addressed the topic of CPOE versus BCMA was met head on.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Dr Wachter restated his politically based, non-evidenced view from &lt;a href="http://www.the-hospitalist.org/blogs/wachters_world/archive/2008/05/02/should-a-hospital-install-bar-coding-or-cpoe-first-why-i-ve-changed-my-tune.aspx"&gt;his blog&lt;/a&gt;. &lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Dr. Bates disagreed on two fronts.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;First the epidemiological studies are clear – more harm is done from mistakes in prescribing.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Second, the best evidence for safety is with CPOE.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;There was agreement that optimally both should be done.&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;For me the answer seems crystal clear.&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;p class="MsoNormal"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-4339359997070293680?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/4339359997070293680/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/09/cpoe-v-bcma.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4339359997070293680'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/4339359997070293680'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/09/cpoe-v-bcma.html' title='CPOE v BCMA'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-7877971424372580141</id><published>2008-09-25T05:50:00.001-07:00</published><updated>2008-09-25T05:50:43.899-07:00</updated><title type='text'>Top Blogs</title><content type='html'>&lt;div&gt;&amp;nbsp;Clipped from: &lt;a href="http://www.rncentral.com/nursing-library/careplans/top_50_health_2.0_blogs"&gt;http://www.rncentral.com/nursing-library/careplans/top_50_health_2.0_blogs&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;Health and Technology&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;Health 2.0 is inextricably linked to technology, so read about how technology and health care affect each other in these blogs.&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;32. Health Populi. Written by a health economist, this blog looks at how health care and technology intersect. Recent posts include health care debt trends and the economic impact on health insurance, medical treatment, and prescription drug use.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;33. iHealthBeat. Actually more of a journal than a blog, this site offers updates on Monday through Friday on how technology affects the health care industry. A part of the California HealthCare Foundation, some of the news is a bit more geared to California and the west coast.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;34. HIStalk. This Health IT blog serves primarily as a news aggregator for all the HIS inside industry scoops, but it also provides reader-written posts about the industry.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;35. The Healthcare IT Guy. Written by a CEO of a health care IT company, this blog offers plenty of reviews for great health 2.0 sites as well as updates about health care as it pertains to technology.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;36. eHealth. Blogging on the nuances of eHealth, health 2.0, and medicine 2.0, this writer discusses the various aspects of technology and health care systems.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;37. Neil Versel's Healthcare IT Blog. Read about podcasting, blogging, open source, privacy and more as these aspects of technology pertain to the health care industry.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;38. Future of Health IT. This news aggregator blog lets you know the latest news on IT trends and happenings as they relate to the health care industry.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;39. The Healthcare Information Systems Blog. While currently undergoing a re-focusing of direction, this blog generally examines health care and its association with technology innovation.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;40. Efficient MD.com. This site offers the latest on technology, best practices, and lifehacks. Stay on top of what technology your physician has available in her field.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;41. Kidney Notes. Not necessarily just focusing on kidneys, this blog offers a good mix of medical technology news, funny journal articles, and other random fun-ness. Medical professionals and laypeople alike will enjoy reading this blog.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;42. davidrothman.net. Combining medical librarianship and Internet technology, this blog offers great 2.0 tools and tips for those in the health care industry.&lt;/div&gt;&lt;div&gt;&amp;nbsp;&amp;nbsp;43. Laika's MedLibLog. Another blog heavy on the medical library end of health 2.0 and written by a Dutch medical information specialist, this blog offers topics such as WikiMindMap, Dutch medical blogs, and more.&amp;nbsp;&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;From Public Pharmacoinformatics — Pharmcoinformatics Public Site&amp;nbsp;&lt;/div&gt;&lt;div&gt;&lt;span class="Apple-style-span" style="font-size: 12px; "&gt;&lt;a href="http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics"&gt;http://www.evernote.com/pub/poikonen/PublicPharmacoinformatics&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;font class="Apple-style-span" size="3"&gt;&lt;span class="Apple-style-span" style="font-size: 12px;"&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div apple-content-edited="true"&gt; &lt;span class="Apple-style-span" style="border-collapse: separate; color: rgb(0, 0, 0); font-family: Helvetica; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0; "&gt;&lt;div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "&gt;&lt;span class="Apple-style-span" style="border-collapse: separate; -webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; -webkit-text-decorations-in-effect: none; text-indent: 0px; -webkit-text-size-adjust: auto; text-transform: none; orphans: 2; white-space: normal; widows: 2; word-spacing: 0px; "&gt;&lt;div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "&gt;&lt;span class="Apple-style-span" style="border-collapse: separate; -webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; color: rgb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; -webkit-text-decorations-in-effect: none; text-indent: 0px; -webkit-text-size-adjust: auto; text-transform: none; orphans: 2; white-space: normal; widows: 2; word-spacing: 0px; "&gt;&lt;div&gt;John Poikonen&lt;/div&gt;&lt;div&gt;&lt;a href="mailto:john@poikonen.net"&gt;john@poikonen.net&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;br class="khtml-block-placeholder"&gt;&lt;/div&gt;&lt;br class="Apple-interchange-newline"&gt;&lt;/span&gt;&lt;/div&gt;&lt;/span&gt;&lt;/div&gt;&lt;/span&gt;&lt;br class="Apple-interchange-newline"&gt; &lt;/div&gt;&lt;br&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-7877971424372580141?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/7877971424372580141/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/09/top-blogs.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/7877971424372580141'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/7877971424372580141'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/09/top-blogs.html' title='Top Blogs'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6037355450143152524.post-229223759737421311</id><published>2008-09-16T10:01:00.000-07:00</published><updated>2008-09-16T10:04:40.602-07:00</updated><title type='text'>Pharmacy Informatics Information Collaborative Exchange</title><content type='html'>Various professional medical and pharmacy organizations have informatic ideas, programs, initiatives going on.  The idea that came out of the AMIA Pharmacoinformatics working group is to coordinate the various activities.  &lt;br /&gt;&lt;br /&gt;The idea would be a representative from AMIA, HIMSS, ASHP and other organizations will use this communication tool for the fostering of input, ideas and collaboration on the advancement of pharmacy informatics.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/6037355450143152524-229223759737421311?l=pharmacyinformatics.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacyinformatics.blogspot.com/feeds/229223759737421311/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/09/pharmacy-informatics-information.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/229223759737421311'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6037355450143152524/posts/default/229223759737421311'/><link rel='alternate' type='text/html' href='http://pharmacyinformatics.blogspot.com/2008/09/pharmacy-informatics-information.html' title='Pharmacy Informatics Information Collaborative Exchange'/><author><name>John Poikonen, PharmD</name><uri>http://www.blogger.com/profile/03597435301999332159</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>
